{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:14:20Z","timestamp":1793751260135,"version":"4.6.1"},"reference-count":547,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Precision medicine has become a cornerstone in modern therapeutic strategies, with nucleic acid aptamers emerging as pivotal tools due to their unique properties. These oligonucleotide fragments, selected through the Systematic Evolution of Ligands by Exponential Enrichment process, exhibit high affinity and specificity toward their targets, such as DNA, RNA, proteins, and other biomolecules. Nucleic acid aptamers offer significant advantages over traditional therapeutic agents, including superior biological stability, minimal immunogenicity, and the capacity for universal chemical modifications that enhance their in vivo performance and targeting precision. In the realm of osseous tissue repair and regeneration, a complex physiological process essential for maintaining skeletal integrity, aptamers have shown remarkable potential in influencing molecular pathways crucial for bone regeneration, promoting osteogenic differentiation and supporting osteoblast survival. By engineering aptamers to regulate inflammatory responses and facilitate the proliferation and differentiation of fibroblasts, these oligonucleotides can be integrated into advanced drug delivery systems, significantly improving bone repair efficacy while minimizing adverse effects. Aptamer-mediated strategies, including the use of siRNA and miRNA mimics or inhibitors, have shown efficacy in enhancing bone mass and microstructure. These approaches hold transformative potential for treating a range of orthopedic conditions like osteoporosis, osteosarcoma, and osteoarthritis. This review synthesizes the molecular mechanisms and biological roles of aptamers in orthopedic diseases, emphasizing their potential to drive innovative and effective therapeutic interventions.<\/jats:p>","DOI":"10.1038\/s41413-025-00447-8","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T07:56:28Z","timestamp":1753343788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders"],"prefix":"10.1038","volume":"13","author":[{"given":"Zhenhong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"447_CR1","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1039\/C4CS00357H","volume":"44","author":"H Ma","year":"2015","unstructured":"Ma, H. et al. Nucleic acid aptamers in cancer research, diagnosis and therapy. Chem. Soc. Rev. 44, 1240\u20131256 (2015).","journal-title":"Chem. Soc. Rev."},{"key":"447_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.2200121","volume":"249","author":"C Tuerk","year":"1990","unstructured":"Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505\u2013510 (1990).","journal-title":"Science"},{"key":"447_CR3","doi-asserted-by":"publisher","first-page":"972933","DOI":"10.3389\/fbioe.2022.972933","volume":"10","author":"F Gao","year":"2022","unstructured":"Gao, F. et al. Recent advances in aptamer-based targeted drug delivery systems for cancer therapy. Front. Bioeng. Biotechnol. 10, 972933 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"447_CR4","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1021\/jacs.1c12593","volume":"144","author":"X Hu","year":"2022","unstructured":"Hu, X. et al. Structure-guided designing pre-organization in bivalent aptamers. J. Am. Chem. Soc. 144, 4507\u20134514 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"447_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1517\/14712598.2012.684875","volume":"12","author":"M Di Matteo","year":"2012","unstructured":"Di Matteo, M., Belay, E., Chuah, M. K. & VandenDriessche, T. Recent developments in transposon-mediated gene therapy. Expert Opin. Biol. Ther. 12, 841\u2013858 (2012).","journal-title":"Expert Opin. Biol. Ther."},{"key":"447_CR6","doi-asserted-by":"publisher","first-page":"e1543","DOI":"10.1002\/wnan.1543","volume":"11","author":"P Sivakumar","year":"2018","unstructured":"Sivakumar, P., Kim, S., Kang, H. C. & Shim, M. S. Targeted siRNA delivery using aptamer\u2010siRNA chimeras and aptamer\u2010conjugated nanoparticles. WIREs Nanomed. Nanobiotechnology 11, e1543 (2018).","journal-title":"WIREs Nanomed. Nanobiotechnology"},{"key":"447_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","volume":"342","author":"Y Yan","year":"2022","unstructured":"Yan, Y. et al. Non-viral vectors for RNA delivery. J. Control. Release 342, 241\u2013279 (2022).","journal-title":"J. Control. Release"},{"key":"447_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","volume":"37","author":"Y Weng","year":"2019","unstructured":"Weng, Y., Xiao, H., Zhang, J., Liang, X.-J. & Huang, Y. RNAi therapeutic and its innovative biotechnological evolution. Biotechnol. Adv. 37, 801\u2013825 (2019).","journal-title":"Biotechnol. Adv."},{"key":"447_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/346818a0","volume":"346","author":"AD Ellington","year":"1990","unstructured":"Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818\u2013822 (1990).","journal-title":"Nature"},{"key":"447_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/344467a0","volume":"344","author":"DL Robertson","year":"1990","unstructured":"Robertson, D. L. & Joyce, G. F. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 344, 467\u2013468 (1990).","journal-title":"Nature"},{"key":"447_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"447_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrg1125","volume":"4","author":"S Kuersten","year":"2003","unstructured":"Kuersten, S. & Goodwin, E. B. The power of the 3\u2032 UTR: translational control and development. Nat. Rev. Genet. 4, 626\u2013637 (2003).","journal-title":"Nat. Rev. Genet."},{"key":"447_CR13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843\u2013854 (1993).","journal-title":"Cell"},{"key":"447_CR14","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1126\/science.7510417","volume":"263","author":"RD Jenison","year":"1994","unstructured":"Jenison, R. D., Gill, S. C., Pardi, A. & Polisky, B. High-resolution molecular discrimination by RNA. Science 263, 1425\u20131429 (1994).","journal-title":"Science"},{"key":"447_CR15","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1021\/ja0038171","volume":"123","author":"MN Stojanovic","year":"2001","unstructured":"Stojanovic, M. N., de Prada, P. & Landry, D. W. Aptamer-based folding fluorescent sensor for cocaine. J. Am. Chem. Soc. 123, 4928\u20134931 (2001).","journal-title":"J. Am. Chem. Soc."},{"key":"447_CR16","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1021\/ja056957p","volume":"128","author":"BR Baker","year":"2006","unstructured":"Baker, B. R. et al. An electronic, aptamer-based small-molecule sensor for the rapid, label-free detection of cocaine in adulterated samples and biological fluids. J. Am. Chem. Soc. 128, 3138\u20133139 (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"447_CR17","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.3390\/s8074296","volume":"8","author":"B Strehlitz","year":"2008","unstructured":"Strehlitz, B., Nikolaus, N. & Stoltenburg, R. Protein detection with aptamer biosensors. Sensors 8, 4296\u20134307 (2008).","journal-title":"Sensors"},{"key":"447_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1006\/abio.2001.5169","volume":"294","author":"N Hamaguchi","year":"2001","unstructured":"Hamaguchi, N., Ellington, A. & Stanton, M. Aptamer beacons for the direct detection of proteins. Anal. Biochem. 294, 126\u2013131 (2001).","journal-title":"Anal. Biochem."},{"key":"447_CR19","doi-asserted-by":"publisher","first-page":"15416","DOI":"10.1073\/pnas.2136683100","volume":"100","author":"DA Daniels","year":"2003","unstructured":"Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M. & Gold, L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. 100, 15416\u201315421 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"447_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrd3141","volume":"9","author":"AD Keefe","year":"2010","unstructured":"Keefe, A. D., Pai, S. & Ellington, A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537\u2013550 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"447_CR21","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s00125-009-1493-6","volume":"52","author":"SG Sayyed","year":"2009","unstructured":"Sayyed, S. G. et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1\/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 52, 2445\u20132454 (2009).","journal-title":"Diabetologia"},{"key":"447_CR22","doi-asserted-by":"publisher","first-page":"8149","DOI":"10.1002\/anie.200602251","volume":"45","author":"V Bagalkot","year":"2006","unstructured":"Bagalkot, V., Farokhzad, O. C., Langer, R. & Jon, S. An aptamer\u2013doxorubicin physical conjugate as a novel targeted drug\u2010delivery platform. Angew. Chem. Int. Ed. 45, 8149\u20138152 (2006).","journal-title":"Angew. Chem. Int. Ed."},{"key":"447_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41551-018-0190-5","volume":"2","author":"M Poudineh","year":"2018","unstructured":"Poudineh, M., Sargent, E. H., Pantel, K. & Kelley, S. O. Profiling circulating tumour cells and other biomarkers of invasive cancers. Nat. Biomed. Eng. 2, 72\u201384 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"447_CR24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/ac802092j","volume":"81","author":"JA Phillips","year":"2008","unstructured":"Phillips, J. A., Xu, Y., Xia, Z., Fan, Z. H. & Tan, W. Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal. Chem. 81, 1033\u20131039 (2008).","journal-title":"Anal. Chem."},{"key":"447_CR25","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1039\/c2lc40411g","volume":"12","author":"J Zhu","year":"2012","unstructured":"Zhu, J., Nguyen, T., Pei, R., Stojanovic, M. & Lin, Q. Specific capture and temperature-mediated release of cells in an aptamer-based microfluidic device. Lab Chip 12, 3504\u20133513 (2012).","journal-title":"Lab Chip"},{"key":"447_CR26","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1039\/C5CC02052B","volume":"51","author":"J Kim","year":"2015","unstructured":"Kim, J., Lee, E., Kang, Y. Y. & Mok, H. Multivalent aptamer\u2013RNA based fluorescent probes for carrier-free detection of cellular microRNA-34a in mucin1-expressing cancer cells. Chem. Commun. 51, 9038\u20139041 (2015).","journal-title":"Chem. Commun."},{"key":"447_CR27","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1021\/acs.analchem.0c01394","volume":"92","author":"Y Song","year":"2020","unstructured":"Song, Y. et al. Discovery of aptamers targeting the receptor-binding domain of the SARS-CoV-2 spike glycoprotein. Anal. Chem. 92, 9895\u20139900 (2020).","journal-title":"Anal. Chem."},{"key":"447_CR28","doi-asserted-by":"publisher","first-page":"10361","DOI":"10.1002\/ange.202100345","volume":"133","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Neutralizing aptamers block S\/RBD\u2010ACE2 interactions and prevent host cell infection. Angew. Chem. 133, 10361\u201310366 (2021).","journal-title":"Angew. Chem."},{"key":"447_CR29","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.1002\/ange.202100316","volume":"133","author":"A Schmitz","year":"2021","unstructured":"Schmitz, A. et al. A SARS\u2010CoV\u20102 spike binding DNA aptamer that inhibits pseudovirus infection by an RBD\u2010independent mechanism.Angew. Chem. 133, 10367\u201310373 (2021).","journal-title":"Angew. Chem."},{"key":"447_CR30","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1002\/anie.202100225","volume":"60","author":"M Sun","year":"2021","unstructured":"Sun, M. et al. Aptamer blocking strategy inhibits SARS\u2010CoV\u20102 virus infection. Angew. Chem. Int. Ed. 60, 10266\u201310272 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"447_CR31","doi-asserted-by":"publisher","first-page":"12157","DOI":"10.1039\/D0SC03920A","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu, R., He, L., Hu, Y., Luo, Z. & Zhang, J. A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers. Chem. Sci. 11, 12157\u201312164 (2020).","journal-title":"Chem. Sci."},{"key":"447_CR32","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1021\/jacs.9b10510","volume":"142","author":"J He","year":"2020","unstructured":"He, J. et al. Molecularly engineering triptolide with aptamers for high specificity and cytotoxicity for triple-negative breast cancer. J. Am. Chem. Soc. 142, 2699\u20132703 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"447_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41392-021-00671-8","volume":"6","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. A new paradigm for artesunate anticancer function: considerably enhancing the cytotoxicity via conjugating artesunate with aptamer. Signal Transduct. Target. Ther. 6, 327 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"447_CR34","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1039\/D1LC00969A","volume":"22","author":"R Gandotra","year":"2022","unstructured":"Gandotra, R. et al. Aptamer selection against alpha-defensin human neutrophil peptide 1 on an integrated microfluidic system for diagnosis of periprosthetic joint infections. Lab Chip 22, 250\u2013261 (2022).","journal-title":"Lab Chip"},{"key":"447_CR35","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1021\/acs.analchem.3c00767","volume":"95","author":"T-W Chen","year":"2023","unstructured":"Chen, T.-W. et al. Automatic detection of two synovial fluid periprosthetic joint infection biomarkers on an integrated microfluidic system. Anal. Chem. 95, 7693\u20137701 (2023).","journal-title":"Anal. Chem."},{"key":"447_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.tcb.2009.05.002","volume":"19","author":"HJ Lipps","year":"2009","unstructured":"Lipps, H. J. & Rhodes, D. G-quadruplex structures: in vivo evidence and function. Trends Cell Biol. 19, 414\u2013422 (2009).","journal-title":"Trends Cell Biol."},{"key":"447_CR37","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.2174\/092986711797189565","volume":"18","author":"RE Wang","year":"2011","unstructured":"Wang, R. E., Wu, H., Niu, Y. & Cai, J. Improving the stability of aptamers by chemical modification. Curr. Med. Chem. 18, 4126\u20134138 (2011).","journal-title":"Curr. Med. Chem."},{"key":"447_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/cmdc.200900444","volume":"5","author":"S Shukla","year":"2010","unstructured":"Shukla, S., Sumaria, C. S. & Pradeepkumar, P. I. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook. Chem. Med. Chem.5, 328\u2013349 (2010).","journal-title":"Chem. Med. Chem."},{"key":"447_CR39","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00216-024-05174-3","volume":"416","author":"GK Uppal","year":"2024","unstructured":"Uppal, G. K., Poolsup, S., Zaripov, E., Gu, Y. & Berezovski, M. V. Comparative analysis of aptamers binding to SARS-CoV-2 N protein using capillary electrophoresis and bio-layer interferometry. Anal. Bioanal. Chem. 416, 1697\u20131705 (2024).","journal-title":"Anal. Bioanal. Chem."},{"key":"447_CR40","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"F Gelain","year":"2010","unstructured":"Gelain, F. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"447_CR41","doi-asserted-by":"publisher","first-page":"19971","DOI":"10.1073\/pnas.1213933109","volume":"109","author":"DR Davies","year":"2012","unstructured":"Davies, D. R. et al. Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets. Proc. Natl. Acad. Sci. USA 109, 19971\u201319976 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"447_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2556","volume":"31","author":"M Kimoto","year":"2013","unstructured":"Kimoto, M., Yamashige, R., Matsunaga, K.-I., Yokoyama, S. & Hirao, I. Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Nat. Biotechnol. 31, 453\u2013457 (2013).","journal-title":"Nat. Biotechnol."},{"key":"447_CR43","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1021\/ja908035g","volume":"132","author":"JD Vaught","year":"2010","unstructured":"Vaught, J. D. et al. Expanding the chemistry of DNA for in vitro selection. J. Am. Chem. Soc. 132, 4141\u20134151 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"447_CR44","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1074\/jbc.M110.178426","volume":"286","author":"MD Moore","year":"2011","unstructured":"Moore, M. D. et al. Protection of HIV neutralizing aptamers against rectal and vaginal nucleases. J. Biol. Chem. 286, 2526\u20132535 (2011).","journal-title":"J. Biol. Chem."},{"key":"447_CR45","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1021\/acs.chemrev.0c01140","volume":"121","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. Aptamer-based detection of circulating targets for precision medicine. Chem. Rev. 121, 12035\u201312105 (2021).","journal-title":"Chem. Rev."},{"key":"447_CR46","doi-asserted-by":"publisher","first-page":"8350","DOI":"10.1002\/anie.200802077","volume":"47","author":"PME Gramlich","year":"2008","unstructured":"Gramlich, P. M. E., Wirges, C. T., Manetto, A. & Carell, T. Postsynthetic DNA modification through the copper\u2010catalyzed azide\u2013alkyne cycloaddition reaction. Angew. Chem. Int. Ed. 47, 8350\u20138358 (2008).","journal-title":"Angew. Chem. Int. Ed."},{"key":"447_CR47","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1021\/ac801285a","volume":"81","author":"Y-H Lao","year":"2009","unstructured":"Lao, Y.-H., Peck, K. & Chen, L.-C. Enhancement of aptamer microarray sensitivity through spacer optimization and avidity effect. Anal. Chem. 81, 1747\u20131754 (2009).","journal-title":"Anal. Chem."},{"key":"447_CR48","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1073\/pnas.0711714105","volume":"105","author":"F Gu","year":"2008","unstructured":"Gu, F. et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl. Acad. Sci. USA 105, 2586\u20132591 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"447_CR49","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3390\/molecules21121613","volume":"21","author":"M Vorobyeva","year":"2016","unstructured":"Vorobyeva, M., Vorobjev, P. & Venyaminova, A. Multivalent aptamers: versatile tools for diagnostic and therapeutic applications. Molecules 21, 1613 (2016).","journal-title":"Molecules"},{"key":"447_CR50","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1021\/nn4023747","volume":"7","author":"W Sheng","year":"2013","unstructured":"Sheng, W., Chen, T., Tan, W. & Fan, Z. H. Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices. ACS Nano 7, 7067\u20137076 (2013).","journal-title":"ACS Nano"},{"key":"447_CR51","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1093\/nar\/gkab574","volume":"49","author":"J Li","year":"2021","unstructured":"Li, J. et al. Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library. Nucleic Acids Res. 49, 7267\u20137279 (2021).","journal-title":"Nucleic Acids Res."},{"key":"447_CR52","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.apsb.2023.01.017","volume":"13","author":"J He","year":"2023","unstructured":"He, J. et al. Recent progress of aptamer\u2012drug conjugates in cancer therapy. Acta Pharm. Sin. B 13, 1358\u20131370 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"447_CR53","doi-asserted-by":"publisher","first-page":"15908","DOI":"10.1073\/pnas.0808360105","volume":"105","author":"C Chen","year":"2008","unstructured":"Chen, C. et al. Aptamer-based endocytosis of a lysosomal enzyme. Proc. Natl. Acad. Sci. USA 105, 15908\u201315913 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"447_CR54","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1158\/0008-5472.CAN-05-4583","volume":"66","author":"T Chu","year":"2006","unstructured":"Chu, T. et al. Aptamer: toxin conjugates that specifically target prostate tumor cells. Cancer Res. 66, 5989\u20135992 (2006).","journal-title":"Cancer Res."},{"key":"447_CR55","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nbt1223","volume":"24","author":"J McNamara","year":"2006","unstructured":"McNamara, J. et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24, 1005\u20131015 (2006).","journal-title":"Nat. Biotechnol."},{"key":"447_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05429-8","volume":"22","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release. J. Transl. Med. 22, 604 (2024).","journal-title":"J. Transl. Med."},{"key":"447_CR57","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1021\/acssensors.3c02034","volume":"9","author":"R Gandotra","year":"2024","unstructured":"Gandotra, R., Wu, H., Kuo, F., Lee, M. & Lee, G. Advancing the diagnosis of periprosthetic joint infections: integrated microfluidic platform for alpha-defensins-specific aptamer selection and its analytical applications. ACS Sens. 9, 1775\u20131784 (2024).","journal-title":"ACS Sens."},{"key":"447_CR58","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1021\/ac201269f","volume":"83","author":"S Oh","year":"2011","unstructured":"Oh, S. et al. Improving aptamer selection efficiency through volume dilution, magnetic concentration, and continuous washing in microfluidic channels. Anal. Chem. 83, 6883\u20136889 (2011).","journal-title":"Anal. Chem."},{"key":"447_CR59","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1038\/mtna.2014.74","volume":"4","author":"M Blind","year":"2015","unstructured":"Blind, M. & Blank, M. Aptamer selection technology and recent advances. Mol. Ther. Nucleic Acids 4, e223 (2015).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"447_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"Z Jiehua","year":"2017","unstructured":"Jiehua, Z. & John, R. Aptamers as targeted therapeutics: current potential and challenges. Nat. Rev. Drug Discov. 16, 181\u2013202 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"447_CR61","doi-asserted-by":"publisher","first-page":"1044126","DOI":"10.3389\/fmolb.2022.1044126","volume":"9","author":"M Luca","year":"2022","unstructured":"Luca, M., Francesca Anna, C., Grazisa, R. & Federica, C. An overview of structural approaches to study therapeutic RNAs. Front. Mol. Biosci. 9, 1044126 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"447_CR62","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3390\/cancers12102889","volume":"12","author":"A Paola","year":"2020","unstructured":"Paola, A., Soumen, K., Cristian, R.-A. & Gabriel, L.-B. Aptamers: novel therapeutics and potential role in neuro-oncology. Cancers 12, 2889 (2020).","journal-title":"Cancers"},{"key":"447_CR63","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/pharmaceutics12100955","volume":"12","author":"Y Farzana","year":"2020","unstructured":"Farzana, Y., Hana, S., Nasir, J., Moon Suk, K. & Sangdun, C. Therapeutic interventions into innate immune diseases by means of aptamers. Pharmaceutics 12, 955 (2020).","journal-title":"Pharmaceutics"},{"key":"447_CR64","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.sbi.2016.01.009","volume":"36","author":"G Amy D","year":"2016","unstructured":"Amy D, G., Douglas R, D. & Nebojsa, J. Embracing proteins: structural themes in aptamer-protein complexes. Curr. Opin. Struct. Biol. 36, 122\u2013132 (2016).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"447_CR65","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1021\/cr300468w","volume":"113","author":"T Weihong","year":"2013","unstructured":"Weihong, T., Michael J, D. & Jianhui, J. Aptamers from cell-based selection for bioanalytical applications. Chem. Rev. 113, 2842\u20132862 (2013).","journal-title":"Chem. Rev."},{"key":"447_CR66","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/ijms17030358","volume":"17","author":"Y Yuanyuan","year":"2016","unstructured":"Yuanyuan, Y. et al. Molecular selection, modification and development of therapeutic oligonucleotide aptamers. Int J. Mol. Sci. 17, 358 (2016).","journal-title":"Int J. Mol. Sci."},{"key":"447_CR67","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.3791","volume":"21","author":"L Chao","year":"2015","unstructured":"Chao, L. et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nat. Med. 21, 288\u2013294 (2015).","journal-title":"Nat. Med."},{"key":"447_CR68","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1021\/acscombsci.5b00023","volume":"17","author":"S Fabio M","year":"2015","unstructured":"Fabio M, S., Paolo, M. & Carlotta, G. More DNA-aptamers for small drugs: a capture-SELEX coupled with surface plasmon resonance and high-throughput sequencing. ACS Comb. Sci. 17, 326\u2013333 (2015).","journal-title":"ACS Comb. Sci."},{"key":"447_CR69","first-page":"14","volume":"4","author":"R Annamaria","year":"2016","unstructured":"Annamaria, R. & Maria C, D. Small-molecule binding aptamers: selection strategies, characterization, and applications. Front Chem. 4, 14 (2016).","journal-title":"Front Chem."},{"key":"447_CR70","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1039\/D3SC00439B","volume":"14","author":"Y Lucy F","year":"2023","unstructured":"Lucy F, Y., Melissa, L., Nataly, K. & Suzie H, P. Aptamers 101: aptamer discovery and in vitro applications in biosensors and separations. Chem. Sci. 14, 4961\u20134978 (2023).","journal-title":"Chem. Sci."},{"key":"447_CR71","first-page":"17","volume":"37","author":"S Shingo","year":"2020","unstructured":"Shingo, S. SELEX-based DNA aptamer selection: a perspective from the advancement of separation techniques. Anal. Sci. 37, 17\u201326 (2020).","journal-title":"Anal. Sci."},{"key":"447_CR72","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1002\/anie.201309334","volume":"53","author":"W Jinpeng","year":"2014","unstructured":"Jinpeng, W. et al. Particle display: a quantitative screening method for generating high-affinity aptamers. Angew. Chem. Int. Ed. 53, 4796\u20134801 (2014).","journal-title":"Angew. Chem. Int. Ed."},{"key":"447_CR73","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/acs.accounts.1c00724","volume":"55","author":"D Wu","year":"2022","unstructured":"Wu, D., Gordon, C. K. L., Shin, J. H., Eisenstein, M. & Soh, H. T. Directed evolution of aptamer discovery technologies. Acc. Chem. Res. 55, 685\u2013695 (2022).","journal-title":"Acc. Chem. Res."},{"key":"447_CR74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.smhs.2024.03.006","volume":"7","author":"Q Yu","year":"2025","unstructured":"Yu, Q. et al. Exploring the role of adipokines in exercise-induced inhibition of tumor growth. Sports Med. Health Sci. 7, 143\u2013156 (2025).","journal-title":"Sports Med. Health Sci."},{"key":"447_CR75","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1021\/acschembio.9b00587","volume":"14","author":"CKL Gordon","year":"2019","unstructured":"Gordon, C. K. L. et al. Click-particle display for base-modified aptamer discovery. ACS Chem. Biol. 14, 2652\u20132662 (2019).","journal-title":"ACS Chem. Biol."},{"key":"447_CR76","first-page":"19","volume":"10","author":"R Dimitriou","year":"2013","unstructured":"Dimitriou, R. & Giannoudis, P. V. The genetic profile of bone repair. Clin. Cases Miner. Bone Metab. 10, 19\u201321 (2013).","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"447_CR77","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2106\/00004623-200212000-00001","volume":"84","author":"G Shunmugam","year":"2002","unstructured":"Shunmugam, G. et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Jt. Surg. 84, 2123\u20132134 (2002).","journal-title":"J. Bone Jt. Surg."},{"key":"447_CR78","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/BOT.0b013e318274da8b","volume":"26","author":"B Joseph Jr","year":"2012","unstructured":"Joseph, B. Jr et al. Physiological challenges of bone repair. J. Orthop. Trauma 26, 708\u2013711 (2012).","journal-title":"J. Orthop. Trauma"},{"key":"447_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2106\/JBJS.G.01521","volume":"90","author":"WM Novicoff","year":"2008","unstructured":"Novicoff, W. M. et al. Critical analysis of the evidence for current technologies in bone-healing and repair. J. Bone Jt. Surg. 90, 85\u201391 (2008).","journal-title":"J. Bone Jt. Surg."},{"key":"447_CR80","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00003086-198304000-00005","volume":"174","author":"H Burchardt","year":"1983","unstructured":"Burchardt, H. The biology of bone graft repair. Clin. Orthop. Relat. Res. 174, 28\u201342 (1983).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"447_CR81","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1210\/en.2007-0270","volume":"148","author":"B Roland","year":"2007","unstructured":"Roland, B. & Georges, R. Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148, 2635\u20132643 (2007).","journal-title":"Endocrinology"},{"key":"447_CR82","doi-asserted-by":"publisher","first-page":"110805","DOI":"10.1016\/j.compositesb.2023.110805","volume":"262","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Advances in the application of bone morphogenetic proteins and their derived peptides in bone defect repair. Composites B 262, 110805 (2023).","journal-title":"Composites B"},{"key":"447_CR83","doi-asserted-by":"publisher","first-page":"a031237","DOI":"10.1101\/cshperspect.a031237","volume":"8","author":"MN Wein","year":"2018","unstructured":"Wein, M. N. & Kronenberg, H. M. Regulation of bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med. 8, a031237 (2018).","journal-title":"Cold Spring Harb Perspect Med."},{"key":"447_CR84","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","volume":"40","author":"RL Jilka","year":"2007","unstructured":"Jilka, R. L. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40, 1434\u20131446 (2007).","journal-title":"Bone"},{"key":"447_CR85","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1359\/jbmr.070517","volume":"22","author":"W Yongmei","year":"2007","unstructured":"Yongmei, W. et al. IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J. Bone Min. Res. 22, 1329\u20131337 (2007).","journal-title":"J. Bone Min. Res."},{"key":"447_CR86","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbrc.2006.01.044","volume":"341","author":"MM Hurley","year":"2006","unstructured":"Hurley, M. M. et al. Impaired bone anabolic response to parathyroid hormone in Fgf2\u2013\/\u2013 and Fgf2+\/\u2013 mice. Biochem. Biophys. Res. Commun. 341, 989\u2013994 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"447_CR87","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","volume":"17","author":"DD Bikle","year":"2002","unstructured":"Bikle, D. D. et al. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J. Bone Min. Res. 17, 1570\u20131578 (2002).","journal-title":"J. Bone Min. Res."},{"key":"447_CR88","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","volume":"136","author":"H Dobnig","year":"1995","unstructured":"Dobnig, H. & Turner, R. T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136, 3632\u20133638 (1995).","journal-title":"Endocrinology"},{"key":"447_CR89","first-page":"225","volume":"8","author":"L Bente","year":"2017","unstructured":"Bente, L., Serge, F. & David W, D. Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther. Adv. Musculoskelet. Dis. 8, 225\u2013235 (2017).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"447_CR90","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1172\/JCI91699","volume":"127","author":"DH Balani","year":"2017","unstructured":"Balani, D. H., Ono, N. & Kronenberg, H. M. Parathyroid hormone regulates fates of murine osteoblast precursors in vivo. J. Clin. Investig. 127, 3327\u20133338 (2017).","journal-title":"J. Clin. Investig."},{"key":"447_CR91","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","volume":"25","author":"F Yi","year":"2017","unstructured":"Yi, F. et al. Parathyroid hormone directs bone marrow mesenchymal cell fate. Cell Metab. 25, 661\u2013672 (2017).","journal-title":"Cell Metab."},{"key":"447_CR92","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bone.2014.06.006","volume":"66","author":"X Jinhu","year":"2014","unstructured":"Jinhu, X. et al. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. Bone 66, 146\u2013154 (2014).","journal-title":"Bone"},{"key":"447_CR93","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.stem.2010.09.012","volume":"7","author":"W Xiangwei","year":"2010","unstructured":"Xiangwei, W. et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7, 571\u2013580 (2010).","journal-title":"Cell Stem Cell"},{"key":"447_CR94","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/156652311795684777","volume":"11","author":"L Gaurav","year":"2011","unstructured":"Gaurav, L. et al. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. Curr. Gene Ther. 11, 229\u2013240 (2011).","journal-title":"Curr. Gene Ther."},{"key":"447_CR95","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","volume":"85","author":"C Hongwei","year":"2003","unstructured":"Hongwei, C. et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J. Bone Jt. Surg. 85, 1544\u20131552 (2003).","journal-title":"J. Bone Jt. Surg."},{"key":"447_CR96","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1021\/acs.biomac.0c01085","volume":"22","author":"SA Schoonraad","year":"2021","unstructured":"Schoonraad, S. A., Trombold, M. L. & Bryant, S. J. The effects of stably tethered BMP-2 on MC3T3-E1 preosteoblasts encapsulated in a PEG hydrogel. Biomacromolecules 22, 1065\u20131079 (2021).","journal-title":"Biomacromolecules"},{"key":"447_CR97","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1359\/jbmr.1997.12.10.1606","volume":"12","author":"K Hanada","year":"1997","unstructured":"Hanada, K., Dennis, J. E. & Caplan, A. I. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Min. Res. 12, 1606\u20131614 (1997).","journal-title":"J. Bone Min. Res."},{"key":"447_CR98","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/term.41","volume":"1","author":"M Naoki","year":"2007","unstructured":"Naoki, M. et al. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J. Tissue Eng. Regen. Med. 1, 306\u2013313 (2007).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"447_CR99","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2017.01.008","volume":"248","author":"K Behnoush","year":"2017","unstructured":"Behnoush, K. et al. Regeneration of bone using nanoplex delivery of FGF-2 and BMP-2 genes in diaphyseal long bone radial defects in a diabetic rabbit model. J. Control. Release 248, 53\u201359 (2017).","journal-title":"J. Control. Release"},{"key":"447_CR100","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.cclet.2021.10.070","volume":"33","author":"LL Wang","year":"2022","unstructured":"Wang, L. L. et al. Bioactive gelatin cryogels with BMP-2 biomimetic peptide and VEGF: a potential scaffold for synergistically induced osteogenesis. Chin. Chem. Lett. 33, 1956\u20131962 (2022).","journal-title":"Chin. Chem. Lett."},{"key":"447_CR101","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1302\/2046-3758.73.BJR-2017-0270.R1","volume":"7","author":"T Winkler","year":"2018","unstructured":"Winkler, T., Sass, F. A., Duda, G. N. & Schmidt-Bleek, K. A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering: the unsolved challenge. Bone Jt. Res. 7, 232\u2013243 (2018).","journal-title":"Bone Jt. Res."},{"key":"447_CR102","first-page":"116","volume":"18","author":"S Lin","year":"2022","unstructured":"Lin, S. et al. Orchestration of energy metabolism and osteogenesis by Mg facilitates low-dose BMP-2-driven regeneration. Bioact. Mater. 18, 116\u2013127 (2022).","journal-title":"Bioact. Mater."},{"key":"447_CR103","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1242\/dev.02298","volume":"133","author":"T Hill","year":"2006","unstructured":"Hill, T., Taketo, M., Birchmeier, W. & Hartmann, C. Multiple roles of mesenchymal beta-catenin during murine limb patterning. Development. 133, 1219\u20131229 (2006).","journal-title":"Development."},{"key":"447_CR104","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","volume":"8","author":"T Hill","year":"2005","unstructured":"Hill, T., Sp\u00e4ter, D., Taketo, M., Birchmeier, W. & Hartmann, C. Canonical Wnt\/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727\u2013738 (2005).","journal-title":"Dev. Cell"},{"key":"447_CR105","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","volume":"8","author":"T Day","year":"2005","unstructured":"Day, T., Guo, X., Garrett-Beal, L. & Yang, Y. Wnt\/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739\u2013750 (2005).","journal-title":"Dev. Cell"},{"key":"447_CR106","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1073\/pnas.0408742102","volume":"102","author":"C Bennett","year":"2005","unstructured":"Bennett, C. et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. USA 102, 3324\u20133329 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"447_CR107","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1359\/jbmr.2003.18.10.1842","volume":"18","author":"G Rawadi","year":"2003","unstructured":"Rawadi, G., Vayssi\u00e8re, B., Dunn, F., Baron, R. & Roman-Roman, S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 18, 1842\u20131853 (2003).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR108","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"W Simonet","year":"1997","unstructured":"Simonet, W. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309\u2013319 (1997).","journal-title":"Cell"},{"key":"447_CR109","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi, G. et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Investig. 111, 1221\u20131230 (2003).","journal-title":"J. Clin. Investig."},{"key":"447_CR110","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fcell.2020.00325","volume":"8","author":"N Zhang","year":"2020","unstructured":"Zhang, N. et al. Pros and cons of denosumab treatment for osteoporosis and implication for RANKL aptamer therapy. Front. Cell Dev. Biol. 8, 325 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"447_CR111","doi-asserted-by":"publisher","first-page":"21162","DOI":"10.1074\/jbc.M501900200","volume":"280","author":"S Holmen","year":"2005","unstructured":"Holmen, S. et al. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem. 280, 21162\u201321168 (2005).","journal-title":"J. Biol. Chem."},{"key":"447_CR112","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"D Glass","year":"2005","unstructured":"Glass, D. et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751\u2013764 (2005).","journal-title":"Dev. Cell"},{"key":"447_CR113","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra, D. et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156\u2013163 (2007).","journal-title":"Nat. Med."},{"key":"447_CR114","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/ten.teb.2009.0687","volume":"16","author":"P Kolar","year":"2010","unstructured":"Kolar, P. et al. The early fracture hematoma and its potential role in fracture healing. Tissue Eng. B 16, 427\u2013434 (2010).","journal-title":"Tissue Eng. B"},{"key":"447_CR115","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/BOT.0b013e3181ed1361","volume":"24","author":"H Pape","year":"2010","unstructured":"Pape, H. et al. Trauma-induced inflammation and fracture healing. J. Orthop. Trauma 24, 522\u2013525 (2010).","journal-title":"J. Orthop. Trauma"},{"key":"447_CR116","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/17453679308993640","volume":"64","author":"O Grundnes","year":"1993","unstructured":"Grundnes, O. & Reiker\u00e5s, O. The importance of the hematoma for fracture healing in rats. Acta Orthop. Scand. 64, 340\u2013342 (1993).","journal-title":"Acta Orthop. Scand."},{"key":"447_CR117","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1302\/0301-620X.72B5.2211764","volume":"72","author":"K Mizuno","year":"1990","unstructured":"Mizuno, K. et al. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. J. Bone Jt. Surg. 72, 822\u2013829 (1990).","journal-title":"J. Bone Jt. Surg."},{"key":"447_CR118","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1083\/jcb.14.3.357","volume":"14","author":"R Young","year":"1962","unstructured":"Young, R. Cell proliferation and specialization during endochondral osteogenesis in young rats. J. Cell Biol. 14, 357\u2013370 (1962).","journal-title":"J. Cell Biol."},{"key":"447_CR119","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.injury.2007.02.007","volume":"38","author":"R Bielby","year":"2007","unstructured":"Bielby, R., Jones, E. & McGonagle, D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 38, S26\u2013S32 (2007).","journal-title":"Injury"},{"key":"447_CR120","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","volume":"2","author":"P Bianco","year":"2008","unstructured":"Bianco, P., Robey, P. & Simmons, P. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313\u2013319 (2008).","journal-title":"Cell Stem Cell"},{"key":"447_CR121","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/17460751.1.4.497","volume":"1","author":"B Delorme","year":"2006","unstructured":"Delorme, B., Chateauvieux, S. & Charbord, P. The concept of mesenchymal stem cells. Regen. Med. 1, 497\u2013509 (2006).","journal-title":"Regen. Med."},{"key":"447_CR122","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1302\/0301-620X.89B1.18286","volume":"89","author":"K Oe","year":"2007","unstructured":"Oe, K. et al. An in vitro study demonstrating that haematomas found at the site of human fractures contain progenitor cells with multilineage capacity. J. Bone Jt. Surg. 89, 133\u2013138 (2007).","journal-title":"J. Bone Jt. Surg."},{"key":"447_CR123","first-page":"4163","volume":"6","author":"T Sun","year":"2021","unstructured":"Sun, T. et al. In situ bone regeneration with sequential delivery of aptamer and BMP2 from an ECM-based scaffold fabricated by cryogenic free-form extrusion. Bioact. Mater. 6, 4163\u20134175 (2021).","journal-title":"Bioact. Mater."},{"key":"447_CR124","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.3390\/ijms20225805","volume":"20","author":"C Schlickewei","year":"2019","unstructured":"Schlickewei, C. et al. Current and future concepts for the treatment of impaired fracture healing. Int. J. Mol. Sci. 20, 5805 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR125","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1097\/00003246-200009001-00017","volume":"28","author":"S Opal","year":"2000","unstructured":"Opal, S. Phylogenetic and functional relationships between coagulation and the innate immune response. Crit. Care Med. 28, S77\u2013S80 (2000).","journal-title":"Crit. Care Med."},{"key":"447_CR126","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biomaterials.2017.12.025","volume":"196","author":"J Pajarinen","year":"2019","unstructured":"Pajarinen, J. et al. Mesenchymal stem cell-macrophage crosstalk and bone healing. Biomaterials 196, 80\u201389 (2019).","journal-title":"Biomaterials"},{"key":"447_CR127","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.actbio.2021.04.052","volume":"133","author":"C Schlundt","year":"2021","unstructured":"Schlundt, C. et al. The multifaceted roles of macrophages in bone regeneration: a story of polarization, activation and time. Acta biomater. 133, 46\u201357 (2021).","journal-title":"Acta biomater."},{"key":"447_CR128","doi-asserted-by":"publisher","first-page":"680328","DOI":"10.3389\/fendo.2021.680328","volume":"12","author":"Z Li","year":"2021","unstructured":"Li, Z., Wang, Y., Li, S. & Li, Y. Exosomes derived from M2 macrophages facilitate osteogenesis and reduce adipogenesis of BMSCs. Front. Endocrinol. 12, 680328 (2021).","journal-title":"Front. Endocrinol."},{"key":"447_CR129","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.cmet.2020.12.019","volume":"33","author":"W Ying","year":"2021","unstructured":"Ying, W. et al. MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice. Cell Metab. 33, 781\u2013790.e785 (2021).","journal-title":"Cell Metab."},{"key":"447_CR130","doi-asserted-by":"publisher","first-page":"115627","DOI":"10.1016\/j.bone.2020.115627","volume":"141","author":"M Kang","year":"2020","unstructured":"Kang, M. et al. Bone regeneration is mediated by macrophage extracellular vesicles. Bone 141, 115627 (2020).","journal-title":"Bone"},{"key":"447_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00622-5","volume":"18","author":"Y Xiong","year":"2020","unstructured":"Xiong, Y. et al. M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 3. J. Nanobiotechnology 18, 66 (2020).","journal-title":"J. Nanobiotechnology"},{"key":"447_CR132","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/stcltm\/szad052","volume":"12","author":"J Shou","year":"2023","unstructured":"Shou, J. et al. 3WJ RNA nanoparticles-aptamer functionalized exosomes from M2 macrophages target BMSCs to promote the healing of bone fractures. Stem Cells Transl. Med. 12, 758\u2013774 (2023).","journal-title":"Stem Cells Transl. Med."},{"key":"447_CR133","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","volume":"4","author":"O Wiklander","year":"2015","unstructured":"Wiklander, O. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 4, 26316 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"447_CR134","doi-asserted-by":"publisher","first-page":"e12085","DOI":"10.1002\/jev2.12085","volume":"10","author":"M Kang","year":"2021","unstructured":"Kang, M., Jordan, V., Blenkiron, C. & Chamley, L. Biodistribution of extracellular vesicles following administration into animals:a systematic review. J. Extracell. Vesicles 10, e12085 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"447_CR135","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1359\/jbmr.2002.17.3.513","volume":"17","author":"T Cho","year":"2002","unstructured":"Cho, T., Gerstenfeld, L. & Einhorn, T. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res. 17, 513\u2013520 (2002).","journal-title":"J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res."},{"key":"447_CR136","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/00003086-199810001-00003","volume":"355","author":"T Einhorn","year":"1998","unstructured":"Einhorn, T. The cell and molecular biology of fracture healing. Clin. Orthop. Relat. Res. 355, S7\u2013S21 (1998).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"447_CR137","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2106\/00004623-199274040-00023","volume":"74","author":"O Oni","year":"1992","unstructured":"Oni, O. Early histological and ultrastructural changes in medullary fracture callus. J. bone Jt. Surg. Am. Vol. 74, 633\u2013634 (1992).","journal-title":"J. bone Jt. Surg. Am. Vol."},{"key":"447_CR138","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11639-015-0106-z","volume":"29","author":"A Capone","year":"2015","unstructured":"Capone, A., Marongiu, G. & Sirianni, R. L\u2019osteogenesi riparativa. LO SCALPELLO-OTODI Educ. 29, 2\u20139 (2015).","journal-title":"LO SCALPELLO-OTODI Educ."},{"key":"447_CR139","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.injury.2005.07.019","volume":"36","author":"R Dimitriou","year":"2005","unstructured":"Dimitriou, R., Tsiridis, E. & Giannoudis, P. Current concepts of molecular aspects of bone healing. Injury 36, 1392\u20131404 (2005).","journal-title":"Injury"},{"key":"447_CR140","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1369\/jhc.6A6959.2006","volume":"54","author":"L Gerstenfeld","year":"2006","unstructured":"Gerstenfeld, L. et al. Three-dimensional reconstruction of fracture callus morphogenesis. J. Histochem. Cytochem. 54, 1215\u20131228 (2006).","journal-title":"J. Histochem. Cytochem."},{"key":"447_CR141","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/nat.2011.0313","volume":"21","author":"W Rockey","year":"2011","unstructured":"Rockey, W. et al. Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Nucleic Acid Ther. 21, 299\u2013314 (2011).","journal-title":"Nucleic Acid Ther."},{"key":"447_CR142","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3390\/ijms13033341","volume":"13","author":"M Ye","year":"2012","unstructured":"Ye, M. et al. Generating aptamers by cell-SELEX for applications in molecular medicine. Int. J. Mol. Sci. 13, 3341\u20133353 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR143","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/nprot.2010.66","volume":"5","author":"K Sefah","year":"2010","unstructured":"Sefah, K., Shangguan, D., Xiong, X., O'Donoghue, M. & Tan, W. Development of DNA aptamers using cell-SELEX. Nat. Protoc. 5, 1169\u20131185 (2010).","journal-title":"Nat. Protoc."},{"key":"447_CR144","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1002\/art.23943","volume":"58","author":"S Herman","year":"2008","unstructured":"Herman, S. et al. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthritis Rheum. 58, 3041\u20133050 (2008).","journal-title":"Arthritis Rheum."},{"key":"447_CR145","first-page":"666","volume":"123","author":"S Lotinun","year":"2013","unstructured":"Lotinun, S. et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Investig. 123, 666\u2013681 (2013).","journal-title":"J. Clin. Investig."},{"key":"447_CR146","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1432-0436.1990.tb00619.x","volume":"44","author":"J Zernik","year":"1990","unstructured":"Zernik, J., Twarog, K. & Upholt, W. Regulation of alkaline phosphatase and alpha 2(I) procollagen synthesis during early intramembranous bone formation in the rat mandible. Differentiation 44, 207\u2013215 (1990).","journal-title":"Differentiation"},{"key":"447_CR147","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2010.08.036","volume":"400","author":"N Fukushima","year":"2010","unstructured":"Fukushima, N., Hiraoka, K., Shirachi, I., Kojima, M. & Nagata, K. Isolation and characterization of a novel peptide, osteoblast activating peptide (OBAP), associated with osteoblast differentiation and bone formation. Biochem. Biophys. Res. Commun. 400, 157\u2013163 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"447_CR148","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/intimm\/dxh103","volume":"16","author":"S Ishikawa","year":"2004","unstructured":"Ishikawa, S. et al. Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). Int. Immunol. 16, 1019\u20131025 (2004).","journal-title":"Int. Immunol."},{"key":"447_CR149","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1359\/jbmr.1999.14.11.1805","volume":"14","author":"GL Barnes","year":"1999","unstructured":"Barnes, G. L., Kostenuik, P. J., Gerstenfeld, L. C. & Einhorn, T. A. Growth factor regulation of fracture repair. J. Bone Miner. Res. 14, 1805\u20131815 (1999).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR150","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/jcb.10435","volume":"88","author":"LC Gerstenfeld","year":"2003","unstructured":"Gerstenfeld, L. C., Cullinane, D. M., Barnes, G. L., Graves, D. T. & Einhorn, T. A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell Biochem 88, 873\u2013884 (2003).","journal-title":"J. Cell Biochem"},{"key":"447_CR151","doi-asserted-by":"publisher","first-page":"2312260","DOI":"10.1002\/adfm.202312260","volume":"34","author":"BL Cai","year":"2024","unstructured":"Cai, B. L. et al. Construction of multi-module RNA nanoparticles harboring miRNA, AIE, and CH6 aptamer for bone targeting and bone anabolic therapy. Adv. Funct. Mater. 34, 2312260 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"447_CR152","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/jor.22401","volume":"31","author":"JH Holstein","year":"2013","unstructured":"Holstein, J. H. et al. Endostatin inhibits callus remodeling during fracture healing in mice. J. Orthop. Res. 31, 1579\u20131584 (2013).","journal-title":"J. Orthop. Res."},{"key":"447_CR153","first-page":"1159","volume":"128","author":"M Mark","year":"2007","unstructured":"Mark, M., Thomas, H., Lutz, C. & Peter, A. Revascularisation during fracture healing with soft tissue injury. Arch. Orthop. Trauma Surg. 128, 1159\u20131165 (2007).","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"447_CR154","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/00000637-199905000-00002","volume":"42","author":"NM Rowe","year":"1999","unstructured":"Rowe, N. M. et al. Angiogenesis during mandibular distraction osteogenesis. Ann. Plast. Surg. 42, 470\u2013475 (1999).","journal-title":"Ann. Plast. Surg."},{"key":"447_CR155","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5435\/00124635-200105000-00002","volume":"9","author":"TA Einhorn","year":"2001","unstructured":"Einhorn, T. A. & Lee, C. A. Bone regeneration: new findings and potential clinical applications. J. Am. Acad. Orthop. Surg. 9, 157\u2013165 (2001).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"447_CR156","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1050-1738(00)00074-8","volume":"10","author":"H Gerber","year":"2000","unstructured":"Gerber, H. Angiogenesis and bone growth. Trends Cardiovasc. Med. 10, 223\u2013228 (2000).","journal-title":"Trends Cardiovasc. Med."},{"key":"447_CR157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bios.2018.03.037","volume":"110","author":"D Sadegh","year":"2018","unstructured":"Sadegh, D. et al. Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (VEGF): a review. Biosens. Bioelectron. 110, 23\u201337 (2018).","journal-title":"Biosens. Bioelectron."},{"key":"447_CR158","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/ijmm.2012.1058","volume":"30","author":"R Ze","year":"2012","unstructured":"Ze, R. et al. GIT1Y321 phosphorylation is required for ERK1\/2- and PDGF-dependent VEGF secretion from osteoblasts to promote angiogenesis and bone healing. Int J. Mol. Med. 30, 819\u2013825 (2012).","journal-title":"Int J. Mol. Med."},{"key":"447_CR159","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.omtn.2019.12.034","volume":"19","author":"Y Toru","year":"2020","unstructured":"Toru, Y. et al. Binding and structural properties of DNA aptamers with VEGF-A-Mimic Activity. Mol. Ther. Nucleic Acids 19, 1145\u20131152 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"447_CR160","doi-asserted-by":"publisher","first-page":"691013","DOI":"10.3389\/fimmu.2021.691013","volume":"12","author":"L Yang","year":"2021","unstructured":"Yang, L., Junqi, L. & Qianzhou, J. Inflammasomes in alveolar bone loss. Front. Immunol. 12, 691013 (2021).","journal-title":"Front. Immunol."},{"key":"447_CR161","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/prd.12422","volume":"89","author":"Y Bo","year":"2022","unstructured":"Bo, Y. & Cun-Yu, W. Osteoporosis and periodontal diseases\u2013an update on their association and mechanistic links. Periodontol 2000 89, 99\u2013113 (2022).","journal-title":"Periodontol 2000"},{"key":"447_CR162","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1834-7819.2007.00008.x","volume":"53","author":"D I","year":"2008","unstructured":"I, D., S, C. & R, D. P. Ridge preservation: what is it and when should it be considered. Aust. Dent. J. 53, 11\u201321 (2008).","journal-title":"Aust. Dent. J."},{"key":"447_CR163","first-page":"313","volume":"23","author":"S Lars","year":"2003","unstructured":"Lars, S., Ann, W., Lambros, K. & Thorkild, K. Bone healing and soft tissue contour changes following single-tooth extraction: a clinical and radiographic 12-month prospective study. Int J. Periodontics Restor. Dent. 23, 313\u2013323 (2003).","journal-title":"Int J. Periodontics Restor. Dent."},{"key":"447_CR164","doi-asserted-by":"publisher","first-page":"03825","DOI":"10.1096\/fasebj.2021.35.S1.03825","volume":"35","author":"A Su","year":"2021","unstructured":"Su, A., Mitchell, D. & Menegaz, R. The effect of tooth loss on craniofacial morphology. FASEB J. 35, 03825 (2021).","journal-title":"FASEB J."},{"key":"447_CR165","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2842.1986.tb00682.x","volume":"13","author":"LV Christensen","year":"1986","unstructured":"Christensen, L. V. & Ziebert, G. J. Effects of experimental loss of teeth on the temporomandibular joint. J. Oral. Rehabil. 13, 587\u2013598 (1986).","journal-title":"J. Oral. Rehabil."},{"key":"447_CR166","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.14219\/jada.archive.1998.0423","volume":"129","author":"K E","year":"1998","unstructured":"E, K., C, H. & R, G. How dentition status and masticatory function affect nutrient intake. J. Am. Dent. Assoc. 129, 1261\u20131269 (1998).","journal-title":"J. Am. Dent. Assoc."},{"key":"447_CR167","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"Z Binghan","year":"2022","unstructured":"Binghan, Z. et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct. Target Ther. 7, 95 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"447_CR168","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jre.13096","volume":"58","author":"DK Ana","year":"2023","unstructured":"Ana, D. K. et al. Notch signalling cascade and proinflammatory mediators in peri-implant lesions with different RANKL\/OPG ratios\u2013an observational study. J. Periodontal Res. 58, 360\u2013368 (2023).","journal-title":"J. Periodontal Res."},{"key":"447_CR169","first-page":"123","volume":"45","author":"N Nadja","year":"2018","unstructured":"Nadja, N. et al. Notch signaling pathway in apical periodontitis: correlation with bone resorption regulators and proinflammatory cytokines. J. Endod. 45, 123\u2013128 (2018).","journal-title":"J. Endod."},{"key":"447_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99231-x","volume":"11","author":"N Haruna","year":"2021","unstructured":"Haruna, N. et al. The Wnt\/\u03b2-catenin signaling pathway has a healing ability for periapical periodontitis. Sci. Rep. 11, 19673 (2021).","journal-title":"Sci. Rep."},{"key":"447_CR171","doi-asserted-by":"publisher","first-page":"1120457","DOI":"10.3389\/fphar.2023.1120457","volume":"14","author":"J Putri Ayu","year":"2023","unstructured":"Putri Ayu, J. et al. Overview on postmenopausal osteoporosis and periodontitis: the therapeutic potential of phytoestrogens against alveolar bone loss. Front. Pharm. 14, 1120457 (2023).","journal-title":"Front. Pharm."},{"key":"447_CR172","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/ijms23031376","volume":"23","author":"C Chu-Han","year":"2022","unstructured":"Chu-Han, C., Li-Ru, C. & Kuo-Hu, C. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int. J. Mol. Sci. 23, 1376 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR173","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.actbio.2021.12.035","volume":"141","author":"L Fengzhen","year":"2022","unstructured":"Fengzhen, L. et al. Treatment of inflammatory bone loss in periodontitis by stem cell-derived exosomes. Acta Biomater. 141, 333\u2013343 (2022).","journal-title":"Acta Biomater."},{"key":"447_CR174","doi-asserted-by":"publisher","first-page":"107901","DOI":"10.1016\/j.intimp.2021.107901","volume":"99","author":"C Mei-Hua","year":"2021","unstructured":"Mei-Hua, C. et al. HIF-1\u03b1 activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization. Int. Immunopharmacol. 99, 107901 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"447_CR175","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.3390\/ijms24108682","volume":"24","author":"Z Zijiao","year":"2023","unstructured":"Zijiao, Z. et al. Pirfenidone inhibits alveolar bone loss in ligature-induced periodontitis by suppressing the NF-\u03baB signaling pathway in mice. Int. J. Mol. Sci. 24, 8682 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR176","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/ph15081027","volume":"15","author":"W Xinge","year":"2022","unstructured":"Xinge, W. et al. Asperuloside prevents peri-implantitis via suppression of NF-\u03baB and ERK1\/2 on Rats. Pharmaceuticals 15, 1027 (2022).","journal-title":"Pharmaceuticals"},{"key":"447_CR177","first-page":"554","volume":"91","author":"M Iva","year":"2019","unstructured":"Iva, M. et al. The down-regulation of Notch 1 signaling contributes to the severity of bone loss in aggressive periodontitis. J. Periodontol. 91, 554\u2013561 (2019).","journal-title":"J. Periodontol."},{"key":"447_CR178","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/clr.13850","volume":"32","author":"M Iva","year":"2021","unstructured":"Iva, M. et al. Notch down-regulation and inflammatory cytokines and RANKL overexpression involvement in peri-implant mucositis and peri-implantitis: a cross-sectional study. Clin. Oral. Implants Res. 32, 1496\u20131505 (2021).","journal-title":"Clin. Oral. Implants Res."},{"key":"447_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35569-8","volume":"13","author":"M Purwaningrum","year":"2023","unstructured":"Purwaningrum, M., Giachelli, C. M., Osathanon, T., Rattanapuchpong, S. & Sawangmake, C. Dissecting specific Wnt components governing osteogenic differentiation potential by human periodontal ligament stem cells through interleukin-6. Sci. Rep. 13, 9055 (2023).","journal-title":"Sci. Rep."},{"key":"447_CR180","doi-asserted-by":"publisher","first-page":"105629","DOI":"10.1016\/j.archoralbio.2023.105629","volume":"147","author":"L Lihua","year":"2023","unstructured":"Lihua, L. et al. IL-37 alleviates alveolar bone resorption and inflammatory response through the NF-\u03baB\/NLRP3 signaling pathway in male mice with periodontitis. Arch. Oral. Biol. 147, 105629 (2023).","journal-title":"Arch. Oral. Biol."},{"key":"447_CR181","first-page":"679","volume":"54","author":"W Jia-He","year":"2023","unstructured":"Jia-He, W., Shu-Juan, Z., Jing, X. & Chen-Chen, Z.Latest findings on NOD-like receptor family pyrin domain containing protein 3 inflammasome and bone and articular diseases. Sichuan Da Xue Xue Bao Yi Xue Ban 54, 679\u2013684 (2023).","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"447_CR182","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1016\/j.bbagen.2013.07.027","volume":"1830","author":"K Xiangwei","year":"2013","unstructured":"Xiangwei, K. et al. GSK3\u03b2 is a checkpoint for TNF-\u03b1-mediated impaired osteogenic differentiation of mesenchymal stem cells in inflammatory microenvironments. Biochim. Biophys. Acta 1830, 5119\u20135129 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"447_CR183","first-page":"206","volume":"93","author":"S Erik","year":"2017","unstructured":"Erik, S. et al. Molecular mechanism of LPS-induced TNF-\u03b1 biosynthesis in polarized human macrophages. Mol. Immunol. 93, 206\u2013215 (2017).","journal-title":"Mol. Immunol."},{"key":"447_CR184","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","volume":"275","author":"N T","year":"2000","unstructured":"T, N. et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem. Biophys. Res. Commun. 275, 768\u2013775 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"447_CR185","doi-asserted-by":"publisher","first-page":"17944","DOI":"10.1021\/am5047735","volume":"6","author":"L Zhenhua","year":"2014","unstructured":"Zhenhua, L. et al. DNA nanostructure-based universal microarray platform for high-efficiency multiplex bioanalysis in biofluids. ACS Appl. Mater. Interfaces 6, 17944\u201317953 (2014).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"447_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/srep01508","volume":"3","author":"W Yanli","year":"2013","unstructured":"Yanli, W. et al. DNA nanostructure-based Interfacial engineering for PCR-free ultrasensitive electrochemical analysis of microRNA. Sci. Rep. 3, 1508 (2013).","journal-title":"Sci. Rep."},{"key":"447_CR187","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.nano.2018.02.004","volume":"14","author":"Z Mi","year":"2018","unstructured":"Mi, Z. et al. Effect of tetrahedral DNA nanostructures on proliferation and osteo\/odontogenic differentiation of dental pulp stem cells via activation of the notch signaling pathway. Nanomedicine 14, 1227\u20131236 (2018).","journal-title":"Nanomedicine"},{"key":"447_CR188","doi-asserted-by":"publisher","first-page":"e12566","DOI":"10.1111\/cpr.12566","volume":"52","author":"Z Mi","year":"2019","unstructured":"Mi, Z. et al. Effect of tetrahedral DNA nanostructures on proliferation and osteogenic differentiation of human periodontal ligament stem cells. Cell Prolif. 52, e12566 (2019).","journal-title":"Cell Prolif."},{"key":"447_CR189","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1021\/acsami.7b17928","volume":"10","author":"Z Qi","year":"2018","unstructured":"Qi, Z. et al. Anti-inflammatory and antioxidative effects of tetrahedral dna nanostructures via the modulation of macrophage responses. ACS Appl. Mater. Interfaces 10, 3421\u20133430 (2018).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"447_CR190","first-page":"1676","volume":"6","author":"Z Mi","year":"2020","unstructured":"Mi, Z. et al. The protective effect of tetrahedral framework nucleic acids on periodontium under inflammatory conditions. Bioact. Mater. 6, 1676\u20131688 (2020).","journal-title":"Bioact. Mater."},{"key":"447_CR191","doi-asserted-by":"publisher","first-page":"121131","DOI":"10.1016\/j.biomaterials.2021.121131","volume":"278","author":"L Pinxue","year":"2021","unstructured":"Pinxue, L. et al. Chitosan hydrogel\/3D-printed poly(\u03b5-caprolactone) hybrid scaffold containing synovial mesenchymal stem cells for cartilage regeneration based on tetrahedral framework nucleic acid recruitment. Biomaterials 278, 121131 (2021).","journal-title":"Biomaterials"},{"key":"447_CR192","doi-asserted-by":"publisher","first-page":"e2109609","DOI":"10.1002\/adma.202109609","volume":"34","author":"M Wenjuan","year":"2022","unstructured":"Wenjuan, M. et al. Biomimetic nanoerythrosome-coated aptamer-DNA tetrahedron\/maytansine conjugates: pH-Responsive and targeted cytotoxicity for HER2-positive breast cancer. Adv. Mater. 34, e2109609 (2022).","journal-title":"Adv. Mater."},{"key":"447_CR193","doi-asserted-by":"publisher","first-page":"e2203076","DOI":"10.1002\/adhm.202203076","volume":"12","author":"W Wei","year":"2023","unstructured":"Wei, W. et al. Antifibrotic effects of tetrahedral framework nucleic acids by inhibiting macrophage polarization and macrophage-myofibroblast transition in bladder remodeling. Adv. Health. Mater. 12, e2203076 (2023).","journal-title":"Adv. Health. Mater."},{"key":"447_CR194","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1021\/acs.nanolett.3c01502","volume":"23","author":"Y Xi","year":"2023","unstructured":"Xi, Y. et al. Tetrahedral framework nucleic acids inhibit muscular mitochondria-mediated apoptosis and ameliorate muscle atrophy in sarcopenia. Nano Lett. 23, 8816\u20138826 (2023).","journal-title":"Nano Lett."},{"key":"447_CR195","doi-asserted-by":"publisher","first-page":"22334","DOI":"10.1021\/acsnano.3c04462","volume":"17","author":"Y Yangxue","year":"2023","unstructured":"Yangxue, Y. et al. A mitochondrial nanoguard modulates redox homeostasis and bioenergy metabolism in diabetic peripheral neuropathy. ACS Nano 17, 22334\u201322354 (2023).","journal-title":"ACS Nano"},{"key":"447_CR196","doi-asserted-by":"publisher","first-page":"e2302326","DOI":"10.1002\/smll.202302326","volume":"19","author":"Z Yuxuan","year":"2023","unstructured":"Yuxuan, Z. et al. Effects of puerarin-loaded tetrahedral framework nucleic acids on osteonecrosis of the femoral head. Small 19, e2302326 (2023).","journal-title":"Small"},{"key":"447_CR197","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/1941738109350438","volume":"1","author":"AJ Sophia Fox","year":"2009","unstructured":"Sophia Fox, A. J., Bedi, A. & Rodeo, S. A. The basic science of articular cartilage: structure, composition, and function. Sports Health 1, 461\u2013468 (2009).","journal-title":"Sports Health"},{"key":"447_CR198","first-page":"465","volume":"54","author":"JA Buckwalter","year":"2005","unstructured":"Buckwalter, J. A., Mankin, H. J. & Grodzinsky, A. J. Articular cartilage and osteoarthritis. Instr. Course Lect. 54, 465\u2013480 (2005).","journal-title":"Instr. Course Lect."},{"key":"447_CR199","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1089\/ten.tea.2013.0356","volume":"20","author":"L Silvia","year":"2014","unstructured":"Silvia, L. & Henning, M. Bioinspired scaffolds for osteochondral regeneration. Tissue Eng. A 20, 2052\u20132076 (2014).","journal-title":"Tissue Eng. A"},{"key":"447_CR200","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.1016\/j.biomaterials.2011.06.037","volume":"32","author":"EA Makris","year":"2011","unstructured":"Makris, E. A., Hadidi, P. & Athanasiou, K. A. The knee meniscus: structure-function, pathophysiology, current repair techniques, and prospects for regeneration. Biomaterials 32, 7411\u20137431 (2011).","journal-title":"Biomaterials"},{"key":"447_CR201","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/1941738111429419","volume":"4","author":"AJ Fox","year":"2012","unstructured":"Fox, A. J., Bedi, A. & Rodeo, S. A. The basic science of human knee menisci: structure, composition, and function. Sports Health 4, 340\u2013351 (2012).","journal-title":"Sports Health"},{"key":"447_CR202","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/036354658201000205","volume":"10","author":"SP Arnoczky","year":"1982","unstructured":"Arnoczky, S. P. & Warren, R. F. Microvasculature of the human meniscus. Am. J. Sports Med. 10, 90\u201395 (1982).","journal-title":"Am. J. Sports Med."},{"key":"447_CR203","doi-asserted-by":"crossref","unstructured":"Danzig, L., Resnick, D., Gonsalves, M., Akeson, W. H. Blood supply to the normal and abnormal menisci of the human knee. Clin. Orthop. Relat. Res. 172, 271\u2013276 (1983).","DOI":"10.1097\/00003086-198301000-00043"},{"key":"447_CR204","first-page":"142","volume":"2","author":"DV Davies","year":"1948","unstructured":"Davies, D. V. & Edwards, D. A. The blood supply of the synovial membrane and intra-articular structures. Ann. R. Coll. Surg. Engl. 2, 142\u2013146 (1948).","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"447_CR205","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0749-8063(85)80080-3","volume":"1","author":"B Day","year":"1985","unstructured":"Day, B., Mackenzie, W. G., Shim, S. S. & Leung, G. The vascular and nerve supply of the human meniscus. Arthroscopy 1, 58\u201362 (1985).","journal-title":"Arthroscopy"},{"key":"447_CR206","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000143133","volume":"70","author":"R Scapinelli","year":"1968","unstructured":"Scapinelli, R. Studies on the vasculature of the human knee joint. Acta Anat. 70, 305\u2013331 (1968).","journal-title":"Acta Anat."},{"key":"447_CR207","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jbiomech.2017.07.019","volume":"61","author":"F Travascio","year":"2017","unstructured":"Travascio, F. & Jackson, A. R. The nutrition of the human meniscus: a computational analysis investigating the effect of vascular recession on tissue homeostasis. J. Biomech. 61, 151\u2013159 (2017).","journal-title":"J. Biomech."},{"key":"447_CR208","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1051\/bmdcn\/2019090102","volume":"9","author":"K Vadodaria","year":"2019","unstructured":"Vadodaria, K., Kulkarni, A., Santhini, E. & Vasudevan, P. Materials and structures used in meniscus repair and regeneration: a review. Biomedicine 9, 2 (2019).","journal-title":"Biomedicine"},{"key":"447_CR209","first-page":"266","volume":"27","author":"L Hao","year":"2020","unstructured":"Hao, L. et al. Advanced polymer-based drug delivery strategies for meniscal regeneration. Tissue Eng. B Rev. 27, 266\u2013293 (2020).","journal-title":"Tissue Eng. B Rev."},{"key":"447_CR210","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.7150\/thno.44270","volume":"10","author":"L Zong","year":"2020","unstructured":"Zong, L. et al. Biomechanically, structurally and functionally meticulously tailored polycaprolactone\/silk fibroin scaffold for meniscus regeneration. Theranostics 10, 5090\u20135106 (2020).","journal-title":"Theranostics"},{"key":"447_CR211","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1128\/JCM.00840-14","volume":"52","author":"L Zonghuan","year":"2014","unstructured":"Zonghuan, L. & Aixi, Y. Diagnostic value of a PCR-based technique for prosthetic joint infection. J. Clin. Microbiol. 52, 2281\u20132282 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"447_CR212","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1302\/0301-620X.103B5.BJJ-2020-0745.R1","volume":"103-B","author":"H Renke","year":"2021","unstructured":"Renke, H. et al. Better choice of the type of specimen used for untargeted metagenomic sequencing in the diagnosis of periprosthetic joint infections. Bone Jt. J. 103-B, 923\u2013930 (2021).","journal-title":"Bone Jt. J."},{"key":"447_CR213","first-page":"583","volume":"50","author":"M M","year":"2011","unstructured":"M, M. et al. Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection. J. Clin. Microbiol. 50, 583\u2013589 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"447_CR214","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nmat2999","volume":"10","author":"L Xiaohua","year":"2011","unstructured":"Xiaohua, L., Xiaobing, J. & Peter X, M. Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair. Nat. Mater. 10, 398\u2013406 (2011).","journal-title":"Nat. Mater."},{"key":"447_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/srep16225","volume":"5","author":"Y Peck","year":"2015","unstructured":"Peck, Y., He, P., Chilla, G. S., Poh, C. L. & Wang, D. A. A preclinical evaluation of an autologous living hyaline-like cartilaginous graft for articular cartilage repair: a pilot study. Sci. Rep. 5, 16225 (2015).","journal-title":"Sci. Rep."},{"key":"447_CR216","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1126\/science.1222454","volume":"338","author":"DJ Huey","year":"2012","unstructured":"Huey, D. J., Hu, J. C. & Athanasiou, K. A. Unlike bone, cartilage regeneration remains elusive. Science 338, 917\u2013921 (2012).","journal-title":"Science"},{"key":"447_CR217","doi-asserted-by":"publisher","first-page":"1605235","DOI":"10.1002\/adma.201605235","volume":"29","author":"H Xiaoxia","year":"2017","unstructured":"Xiaoxia, H. et al. A difunctional regeneration scaffold for knee repair based on aptamer-directed cell recruitment. Adv. Mater. 29, 1605235 (2017).","journal-title":"Adv. Mater."},{"key":"447_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csm.2004.08.007","volume":"24","author":"P Andrew D","year":"2005","unstructured":"Andrew D, P., Russell F, W. & Scott A, R. Basic science of articular cartilage and osteoarthritis. Clin. Sports Med. 24, 1\u201312 (2005).","journal-title":"Clin. Sports Med."},{"key":"447_CR219","first-page":"477","volume":"47","author":"JA Buckwalter","year":"1998","unstructured":"Buckwalter, J. A. & Mankin, H. J. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr. Course Lect. 47, 477\u2013486 (1998).","journal-title":"Instr. Course Lect."},{"key":"447_CR220","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/cr.2015.7","volume":"25","author":"H Zhonggang","year":"2015","unstructured":"Zhonggang, H. et al. Characterization and target identification of a DNA aptamer that labels pluripotent stem cells. Cell Res. 25, 390\u2013393 (2015).","journal-title":"Cell Res."},{"key":"447_CR221","doi-asserted-by":"publisher","first-page":"e10302","DOI":"10.1002\/btm2.10302","volume":"7","author":"L Hao","year":"2022","unstructured":"Hao, L. et al. Integrated bioactive scaffold with aptamer-targeted stem cell recruitment and growth factor-induced pro-differentiation effects for anisotropic meniscal regeneration. Bioeng. Transl. Med. 7, e10302 (2022).","journal-title":"Bioeng. Transl. Med."},{"key":"447_CR222","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1177\/03635465231159668","volume":"51","author":"C Zhong","year":"2023","unstructured":"Zhong, C. et al. Repairing avascular meniscal lesions by recruiting endogenous targeted cells through bispecific synovial-meniscal aptamers. Am. J. Sports Med. 51, 1177\u20131193 (2023).","journal-title":"Am. J. Sports Med."},{"key":"447_CR223","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino, A. & Marini, J. Osteogenesis imperfecta. Lancet 387, 1657\u20131671 (2016).","journal-title":"Lancet"},{"key":"447_CR224","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0972-6","volume":"14","author":"R Pauli","year":"2019","unstructured":"Pauli, R. Achondroplasia: a comprehensive clinical review. Orphanet J. Rare Dis. 14, 1 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"447_CR225","doi-asserted-by":"publisher","first-page":"1052592","DOI":"10.3389\/fendo.2022.1052592","volume":"13","author":"B Wu","year":"2022","unstructured":"Wu, B. et al. A narrative review of diabetic bone disease: characteristics, pathogenesis, and treatment. Front. Endocrinol. 13, 1052592 (2022).","journal-title":"Front. Endocrinol."},{"key":"447_CR226","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1470-2045(20)30559-3","volume":"22","author":"E Terpos","year":"2021","unstructured":"Terpos, E. et al. Treatment of multiple myeloma-related bone disease: recommendations from the bone working group of the International Myeloma Working Group. Lancet Oncol. 22, e119\u2013e130 (2021).","journal-title":"Lancet Oncol."},{"key":"447_CR227","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/01.bor.0000132647.55056.a9","volume":"16","author":"J Buckwalter","year":"2004","unstructured":"Buckwalter, J. & Martin, J. Sports and osteoarthritis. Curr. Opin. Rheumatol. 16, 634\u2013639 (2004).","journal-title":"Curr. Opin. Rheumatol."},{"key":"447_CR228","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/ani12151946","volume":"12","author":"A Wawrzyniak","year":"2022","unstructured":"Wawrzyniak, A. & Balawender, K. Structural and metabolic changes in bone. Animals 12, 1946 (2022).","journal-title":"Animals"},{"key":"447_CR229","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000351896","volume":"18","author":"W Xiao","year":"2016","unstructured":"Xiao, W., Li, S., Pacios, S., Wang, Y. & Graves, D. Bone remodeling under pathological conditions. Front. Oral. Biol. 18, 17\u201327 (2016).","journal-title":"Front. Oral. Biol."},{"key":"447_CR230","doi-asserted-by":"crossref","unstructured":"Consensus conference: osteoporosis. JAMA. 252, 799-802 (1984).","DOI":"10.1001\/jama.1984.03350060043028"},{"key":"447_CR231","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","volume":"41","author":"L Armas","year":"2012","unstructured":"Armas, L. & Recker, R. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol. Metab. Clin. North Am. 41, 475\u2013486 (2012).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"447_CR232","doi-asserted-by":"crossref","unstructured":"NIH Consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7-29, 2000: highlights of the conference. South Med. J. 94, 569\u2013573 (2001).","DOI":"10.1097\/00007611-200194060-00004"},{"key":"447_CR233","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"N Lane","year":"2006","unstructured":"Lane, N. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 194, S3\u2013S11 (2006).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"447_CR234","first-page":"105","volume":"133","author":"M Clynes","year":"2020","unstructured":"Clynes, M. et al. The epidemiology of osteoporosis. Br. Med. Bull. 133, 105\u2013117 (2020).","journal-title":"Br. Med. Bull."},{"key":"447_CR235","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"T van Staa","year":"2001","unstructured":"van Staa, T., Dennison, E., Leufkens, H. & Cooper, C. Epidemiology of fractures in England and Wales. Bone 29, 517\u2013522 (2001).","journal-title":"Bone"},{"key":"447_CR236","doi-asserted-by":"publisher","first-page":"101551","DOI":"10.1016\/j.beem.2021.101551","volume":"35","author":"A Gosset","year":"2021","unstructured":"Gosset, A., Pouill\u00e8s, J. & Tr\u00e9mollieres, F. Menopausal hormone therapy for the management of osteoporosis. Best. Pract. Res. Clin. Endocrinol. Metab. 35, 101551 (2021).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"447_CR237","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bone.2007.03.019","volume":"41","author":"M Akhter","year":"2007","unstructured":"Akhter, M., Lappe, J., Davies, K. & Recker, R. Transmenopausal changes in the trabecular bone structure. Bone 41, 111\u2013116 (2007).","journal-title":"Bone"},{"key":"447_CR238","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.bone.2006.11.011","volume":"40","author":"D Cooper","year":"2007","unstructured":"Cooper, D. et al. Age-dependent change in the 3D structure of cortical porosity at the human femoral midshaft. Bone 40, 957\u2013965 (2007).","journal-title":"Bone"},{"key":"447_CR239","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1359\/jbmr.081210","volume":"24","author":"L Cardoso","year":"2009","unstructured":"Cardoso, L. et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J. Bone Miner. Res. 24, 597\u2013605 (2009).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR240","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bone.2007.12.224","volume":"42","author":"L Bonewald","year":"2008","unstructured":"Bonewald, L. & Johnson, M. Osteocytes, mechanosensing and Wnt signaling. Bone 42, 606\u2013615 (2008).","journal-title":"Bone"},{"key":"447_CR241","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jbmr.5650110307","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero, P., Sornay-Rendu, E., Chapuy, M. & Delmas, P. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J. Bone Miner. Res. 11, 337\u2013349 (1996).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR242","doi-asserted-by":"publisher","first-page":"197S","DOI":"10.1016\/8756-3282(95)00502-1","volume":"18","author":"B Riggs","year":"1996","unstructured":"Riggs, B., Melton, L. & O'Fallon, W. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 18, 197S\u2013201S (1996).","journal-title":"Bone"},{"key":"447_CR243","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bone.2008.05.024","volume":"43","author":"G Boivin","year":"2008","unstructured":"Boivin, G. et al. The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. Bone 43, 532\u2013538 (2008).","journal-title":"Bone"},{"key":"447_CR244","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1007\/s00198-002-1347-2","volume":"14","author":"G Boivin","year":"2003","unstructured":"Boivin, G. & Meunier, P. The mineralization of bone tissue: a forgotten dimension in osteoporosis research. Osteoporos. Int. 14, S19\u2013S24 (2003).","journal-title":"Osteoporos. Int."},{"key":"447_CR245","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/jbmr.5650050807","volume":"5","author":"A Leblanc","year":"1990","unstructured":"Leblanc, A., Schneider, V., Evans, H., Engelbretson, D. & Krebs, J. Bone mineral loss and recovery after 17 weeks of bed rest. J. Bone Miner. Res. 5, 843\u2013850 (1990).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR246","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/036354658701500107","volume":"15","author":"G Matheson","year":"1987","unstructured":"Matheson, G. et al. Stress fractures in athletes. A study of 320 cases. Am. J. Sports Med. 15, 46\u201358 (1987).","journal-title":"Am. J. Sports Med."},{"key":"447_CR247","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2165\/00007256-199519050-00004","volume":"19","author":"K Khan","year":"1995","unstructured":"Khan, K. et al. Overuse injuries in classical ballet. Sports Med. 19, 341\u2013357 (1995).","journal-title":"Sports Med."},{"key":"447_CR248","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bone.2010.07.006","volume":"47","author":"B Herman","year":"2010","unstructured":"Herman, B., Cardoso, L., Majeska, R., Jepsen, K. & Schaffler, M. Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage. Bone 47, 766\u2013772 (2010).","journal-title":"Bone"},{"key":"447_CR249","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bone.2010.09.014","volume":"48","author":"L Mulcahy","year":"2011","unstructured":"Mulcahy, L., Taylor, D., Lee, T. & Duffy, G. RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. Bone 48, 182\u2013188 (2011).","journal-title":"Bone"},{"key":"447_CR250","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/8756-3282(95)00370-3","volume":"17","author":"M Schaffler","year":"1995","unstructured":"Schaffler, M., Choi, K. & Milgrom, C. Aging and matrix microdamage accumulation in human compact bone. Bone 17, 521\u2013525 (1995).","journal-title":"Bone"},{"key":"447_CR251","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1359\/JBMR.040710","volume":"19","author":"R Recker","year":"2004","unstructured":"Recker, R., Lappe, J., Davies, K. & Heaney, R. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J. Bone Miner. Res. 19, 1628\u20131633 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR252","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrm2234","volume":"8","author":"S Russell","year":"2007","unstructured":"Russell, S. & Kahn, C. Endocrine regulation of ageing. Nat. Rev. Mol. Cell Biol. 8, 681\u2013691 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"447_CR253","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/er.2009-0024","volume":"31","author":"S Manolagas","year":"2010","unstructured":"Manolagas, S. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 31, 266\u2013300 (2010).","journal-title":"Endocr. Rev."},{"key":"447_CR254","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/PL00004150","volume":"7","author":"R Heaney","year":"1997","unstructured":"Heaney, R. et al. Bone dimensional change with age: interactions of genetic, hormonal, and body size variables. Osteoporos. Int. 7, 426\u2013431 (1997).","journal-title":"Osteoporos. Int."},{"key":"447_CR255","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa022464","volume":"349","author":"H Ahlborg","year":"2003","unstructured":"Ahlborg, H., Johnell, O., Turner, C., Rannevik, G. & Karlsson, M. Bone loss and bone size after menopause. N. Engl. J. Med. 349, 327\u2013334 (2003).","journal-title":"N. Engl. J. Med."},{"key":"447_CR256","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00198-010-1369-0","volume":"22","author":"PJ Marie","year":"2010","unstructured":"Marie, P. J., Felsenberg, D. & Brandi, M. L. How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos. Int. 22, 1659\u20131667 (2010).","journal-title":"Osteoporos. Int."},{"key":"447_CR257","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00198-002-1301-3","volume":"14","author":"H H\u00e4uselmann","year":"2003","unstructured":"H\u00e4uselmann, H. & Rizzoli, R. A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos. Int. 14, 2\u201312 (2003).","journal-title":"Osteoporos. Int."},{"key":"447_CR258","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1007\/s00198-002-1340-9","volume":"14","author":"E Seeman","year":"2003","unstructured":"Seeman, E. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos. Int. 14, S2\u2013S8 (2003).","journal-title":"Osteoporos. Int."},{"key":"447_CR259","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/ebm1156","volume":"16","author":"M Etminan","year":"2011","unstructured":"Etminan, M. Long-term use of oral bisphosphonates increases the risk of oesophageal but not gastric or colorectal cancer. Evid.-based Med. 16, 28\u201329 (2011).","journal-title":"Evid.-based Med."},{"key":"447_CR260","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","volume":"11","author":"T Martin","year":"2005","unstructured":"Martin, T. & Sims, N. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11, 76\u201381 (2005).","journal-title":"Trends Mol. Med."},{"key":"447_CR261","doi-asserted-by":"publisher","first-page":"2295432","DOI":"10.1080\/19490976.2023.2295432","volume":"16","author":"Z Yuan-Wei","year":"2024","unstructured":"Yuan-Wei, Z. et al. Diets intervene osteoporosis via gut-bone axis. Gut Microbes 16, 2295432 (2024).","journal-title":"Gut Microbes"},{"key":"447_CR262","doi-asserted-by":"publisher","first-page":"1124945","DOI":"10.3389\/fmicb.2023.1124945","volume":"14","author":"T Ye","year":"2023","unstructured":"Ye, T., Xinyi, K., Ling, Z. & Xin, X. The associations of gut microbiota, endocrine system and bone metabolism. Front. Microbiol. 14, 1124945 (2023).","journal-title":"Front. Microbiol."},{"key":"447_CR263","first-page":"3066","volume":"61","author":"B Luigi","year":"2020","unstructured":"Luigi, B. et al. Nutrition and immune system: from the Mediterranean diet to dietary supplementary through the microbiota. Crit. Rev. Food Sci. Nutr. 61, 3066\u20133090 (2020).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"447_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00976-w","volume":"9","author":"S Joan","year":"2021","unstructured":"Joan, S. et al. High-dose saccharin supplementation does not induce gut microbiota changes or glucose intolerance in healthy humans and mice. Microbiome 9, 11 (2021).","journal-title":"Microbiome"},{"key":"447_CR265","doi-asserted-by":"publisher","first-page":"1409534","DOI":"10.3389\/fmed.2024.1409534","volume":"11","author":"L Zhi Qiang","year":"2024","unstructured":"Zhi Qiang, L. et al. A decade of insight: bibliometric analysis of gut microbiota\u2019s role in osteoporosis (2014-2024). Front. Med. 11, 1409534 (2024).","journal-title":"Front. Med."},{"key":"447_CR266","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/imr.12192","volume":"260","author":"B Calum C","year":"2014","unstructured":"Calum C, B. & Allan McI, M. Macrophages in intestinal homeostasis and inflammation. Immunol. Rev. 260, 102\u2013117 (2014).","journal-title":"Immunol. Rev."},{"key":"447_CR267","doi-asserted-by":"publisher","first-page":"102196","DOI":"10.1016\/j.arr.2024.102196","volume":"94","author":"Z Yuan-Wei","year":"2024","unstructured":"Yuan-Wei, Z., Yan, W., Xiang-Fei, L., Xiao, C. & Jia-Can, S. Targeting the gut microbiota-related metabolites for osteoporosis: the inextricable connection of gut-bone axis. Ageing Res. Rev. 94, 102196 (2024).","journal-title":"Ageing Res. Rev."},{"key":"447_CR268","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/jcp.24487","volume":"229","author":"B Kyunghwa","year":"2014","unstructured":"Kyunghwa, B. et al. TNF-\u03b1 upregulates sclerostin expression in obese mice fed a high-fat diet. J. Cell Physiol. 229, 640\u2013650 (2014).","journal-title":"J. Cell Physiol."},{"key":"447_CR269","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.3390\/ijms21145169","volume":"21","author":"K Hideki","year":"2020","unstructured":"Hideki, K. et al. Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int. J. Mol. Sci. 21, 5169 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR270","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","volume":"182","author":"U N","year":"1995","unstructured":"N, U. et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182, 1461\u20131468 (1995).","journal-title":"J. Exp. Med."},{"key":"447_CR271","doi-asserted-by":"publisher","first-page":"8706","DOI":"10.1074\/jbc.M113.532580","volume":"289","author":"G Shashi","year":"2014","unstructured":"Shashi, G. et al. Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor. J. Biol. Chem. 289, 8706\u20138719 (2014).","journal-title":"J. Biol. Chem."},{"key":"447_CR272","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00864-2","volume":"8","author":"XM Ren","year":"2017","unstructured":"Ren, X. M., Gelinas, A. D., von Carlowitz, I., Janjic, N. & Pyle, A. M. Structural basis for IL-1\u03b1 recognition by a modified DNA aptamer that specifically inhibits IL-1\u03b1 signaling. Nat. Commun. 8, 810 (2017).","journal-title":"Nat. Commun."},{"key":"447_CR273","first-page":"170","volume":"8","author":"O Erik W","year":"2012","unstructured":"Erik W, O., Nick, J., Yuen Lai, S., Sachdev S, S. & Jean, G. A short DNA aptamer that recognizes TNF\u03b1 and blocks its activity in vitro. ACS Chem. Biol. 8, 170\u2013178 (2012).","journal-title":"ACS Chem. Biol."},{"key":"447_CR274","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.biomaterials.2013.09.107","volume":"35","author":"HJ Sung","year":"2014","unstructured":"Sung, H. J. et al. Inhibition of human neutrophil activity by an RNA aptamer bound to interleukin-8. Biomaterials 35, 578\u2013589 (2014).","journal-title":"Biomaterials"},{"key":"447_CR275","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/art.30108","volume":"63","author":"A Ishiguro","year":"2011","unstructured":"Ishiguro, A., Akiyama, T., Adachi, H., Inoue, J. & Nakamura, Y. Therapeutic potential of anti-interleukin-17A aptamer suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. Arthritis Rheum. 63, 455\u2013466 (2011).","journal-title":"Arthritis Rheum."},{"key":"447_CR276","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10522-015-9578-8","volume":"17","author":"D Frasca","year":"2015","unstructured":"Frasca, D. & Blomberg, B. B. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology 17, 7\u201319 (2015).","journal-title":"Biogerontology"},{"key":"447_CR277","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/nu9060555","volume":"9","author":"P-D Julio","year":"2017","unstructured":"Julio, P.-D., Francisco Javier, R.-O., Laura Maria, V.-P. & Angel, G. Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients 9, 555 (2017).","journal-title":"Nutrients"},{"key":"447_CR278","doi-asserted-by":"publisher","first-page":"1007166","DOI":"10.3389\/fncel.2022.1007166","volume":"16","author":"H Haslin Madihah","year":"2022","unstructured":"Haslin Madihah, H. & Suzana, M. A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation. Front. Cell Neurosci. 16, 1007166 (2022).","journal-title":"Front. Cell Neurosci."},{"key":"447_CR279","doi-asserted-by":"publisher","first-page":"e92368","DOI":"10.1371\/journal.pone.0092368","volume":"9","author":"O Claes","year":"2014","unstructured":"Claes, O. et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS ONE 9, e92368 (2014).","journal-title":"PLoS ONE"},{"key":"447_CR280","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30114-4","volume":"8","author":"N Ravinder","year":"2018","unstructured":"Ravinder, N. et al. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. Sci. Rep. 8, 12649 (2018).","journal-title":"Sci. Rep."},{"key":"447_CR281","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02490-4","volume":"9","author":"L S\u00e9bastien","year":"2018","unstructured":"S\u00e9bastien, L. et al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat. Commun. 9, 55 (2018).","journal-title":"Nat. Commun."},{"key":"447_CR282","first-page":"55","volume":"19","author":"F Yong","year":"2020","unstructured":"Yong, F. & Oluf, P. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"447_CR283","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbr.2015.02.044","volume":"287","author":"HM Savignac","year":"2015","unstructured":"Savignac, H. M., Tramullas, M., Kiely, B., Dinan, T. G. & Cryan, J. F. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav. Brain Res. 287, 59\u201372 (2015).","journal-title":"Behav. Brain Res."},{"key":"447_CR284","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1139\/apnm-2017-0648","volume":"43","author":"ANA Somayeh","year":"2018","unstructured":"Somayeh, A. N. A. et al. Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in \u03b2-amyloid (1-42) injected rats. Appl. Physiol. Nutr. Metab. 43, 718\u2013726 (2018).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"447_CR285","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1389200219666180813144834","volume":"15","author":"L Friedrich","year":"2018","unstructured":"Friedrich, L., Kostja, S., Burkhard, S., Dietmar, F. & Johanna M, G. Probiotic supplementation in patients with Alzheimer\u2019s Dementia\u2013an explorative intervention study. Curr. Alzheimer Res. 15, 1106\u20131113 (2018).","journal-title":"Curr. Alzheimer Res."},{"key":"447_CR286","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.apsb.2019.07.001","volume":"10","author":"Y Xueqin","year":"2020","unstructured":"Xueqin, Y., Dongke, Y., Li, X., Hui, L. & Junrong, D. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm. Sin. B 10, 475\u2013487 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"447_CR287","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1039\/D2FO04092A","volume":"14","author":"J Mingjie","year":"2023","unstructured":"Mingjie, J. et al. Preparation of synbiotic milk powder and its effect on calcium absorption and the bone microstructure in calcium deficient mice. Food Funct. 14, 3092\u20133106 (2023).","journal-title":"Food Funct."},{"key":"447_CR288","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"D Bartel","year":"2004","unstructured":"Bartel, D. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"447_CR289","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros, V. The functions of animal microRNAs. Nature 431, 350\u2013355 (2004).","journal-title":"Nature"},{"key":"447_CR290","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"D Bartel","year":"2009","unstructured":"Bartel, D. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"447_CR291","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/15476286.2014.996462","volume":"11","author":"P Tang","year":"2014","unstructured":"Tang, P., Xiong, Q., Ge, W. & Zhang, L. The role of microRNAs in osteoclasts and osteoporosis. RNA Biol. 11, 1355\u20131363 (2014).","journal-title":"RNA Biol."},{"key":"447_CR292","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/ijms17030349","volume":"17","author":"X Ji","year":"2016","unstructured":"Ji, X., Chen, X. & Yu, X. MicroRNAs in osteoclastogenesis and function: potential therapeutic targets for osteoporosis. Int. J. Mol. Sci. 17, 349 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR293","doi-asserted-by":"publisher","first-page":"1219433","DOI":"10.3389\/fendo.2023.1219433","volume":"14","author":"F Meng","year":"2023","unstructured":"Meng, F. et al. A potential therapeutic drug for osteoporosis: prospect for osteogenic LncRNAs. Front. Endocrinol. 14, 1219433 (2023).","journal-title":"Front. Endocrinol."},{"key":"447_CR294","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/jbmr.186","volume":"26","author":"S Lei","year":"2011","unstructured":"Lei, S., Papasian, C. & Deng, H. Polymorphisms in predicted miRNA binding sites and osteoporosis. J. Bone Miner. Res. 26, 72\u201378 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR295","doi-asserted-by":"publisher","first-page":"945310","DOI":"10.3389\/fendo.2022.945310","volume":"13","author":"M Gao","year":"2022","unstructured":"Gao, M., Zhang, Z., Sun, J., Li, B. & Li, Y. The roles of circRNA-miRNA-mRNA networks in the development and treatment of osteoporosis. Front. Endocrinol. 13, 945310 (2022).","journal-title":"Front. Endocrinol."},{"key":"447_CR296","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1111\/jcmm.16906","volume":"25","author":"W Chen","year":"2021","unstructured":"Chen, W., Zhang, B. & Chang, X. Emerging roles of circular RNAs in osteoporosis. J. Cell. Mol. Med. 25, 9089\u20139101 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"447_CR297","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16003","volume":"8","author":"M Yang","year":"2017","unstructured":"Yang, M. et al. MiR-497\u223c195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1\u03b1 activity. Nat. Commun. 8, 16003 (2017).","journal-title":"Nat. Commun."},{"key":"447_CR298","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1172\/JCI77716","volume":"125","author":"C Li","year":"2015","unstructured":"Li, C. et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J. Clin. Investig. 125, 1509\u20131522 (2015).","journal-title":"J. Clin. Investig."},{"key":"447_CR299","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrd3249","volume":"9","author":"AD Keefe","year":"2010","unstructured":"Keefe, A. D., Pai, S. & Ellington, A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 660 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"447_CR300","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms18091851","volume":"18","author":"W Xiaoqiu","year":"2017","unstructured":"Xiaoqiu, W. et al. Potential diagnostic and therapeutic applications of oligonucleotide aptamers in breast cancer. Int. J. Mol. Sci. 18, 1851 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR301","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4155\/tde-2017-0057","volume":"8","author":"DV Haute","year":"2017","unstructured":"Haute, D. V. & Berlin, J. M. Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles. Ther. Deliv. 8, 763\u2013774 (2017).","journal-title":"Ther. Deliv."},{"key":"447_CR302","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/oli.2005.15.183","volume":"15","author":"RM Boomer","year":"2005","unstructured":"Boomer, R. M. et al. Conjugation to polyethylene glycol polymer promotes aptamer biodistribution to healthy and inflamed tissues. Oligonucleotides 15, 183\u2013195 (2005).","journal-title":"Oligonucleotides"},{"key":"447_CR303","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1007\/s11095-004-7676-4","volume":"21","author":"JM Healy","year":"2005","unstructured":"Healy, J. M. et al. Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm. Res. 21, 2234\u20132246 (2005).","journal-title":"Pharm. Res."},{"key":"447_CR304","doi-asserted-by":"publisher","first-page":"e1270","DOI":"10.1542\/peds.2009-3058","volume":"125","author":"MF Bouchard","year":"2010","unstructured":"Bouchard, M. F., Bellinger, D. C., Wright, R. O. & Weisskopf, M. G. Attention-deficit\/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics 125, e1270\u2013e1277 (2010).","journal-title":"Pediatrics"},{"key":"447_CR305","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/PAT.0000000000000050","volume":"46","author":"VY Jo","year":"2014","unstructured":"Jo, V. Y. & Fletcher, C. D. M. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46, 95\u2013104 (2014).","journal-title":"Pathology"},{"key":"447_CR306","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00292-017-0396-4","volume":"39","author":"G Jundt","year":"2017","unstructured":"Jundt, G. [Updates to the WHO classification of bone tumours]. Pathologe 39, 107\u2013116 (2017).","journal-title":"Pathologe"},{"key":"447_CR307","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"113","author":"M Sbaraglia","year":"2020","unstructured":"Sbaraglia, M., Bellan, E. & Dei Tos, A. P. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica 113, 70\u201384 (2020).","journal-title":"Pathologica"},{"key":"447_CR308","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJM199907293410507","volume":"341","author":"CA Arndt","year":"1999","unstructured":"Arndt, C. A. & Crist, W. M. Common musculoskeletal tumors of childhood and adolescence. N. Engl. J. Med. 341, 342\u2013352 (1999).","journal-title":"N. Engl. J. Med."},{"key":"447_CR309","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-6","volume":"2","author":"P Piero","year":"2007","unstructured":"Piero, P. Osteosarcoma (osteogenic sarcoma). Orphanet J. Rare Dis. 2, 6 (2007).","journal-title":"Orphanet J. Rare Dis."},{"key":"447_CR310","first-page":"1978","volume":"42","author":"CA Stiller","year":"2006","unstructured":"Stiller, C. A., Bielack, S. S., Jundt, G. & Steliarova-Foucher, E. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur. J. Cancer 42, 1978\u20131997 (2006).","journal-title":"Eur. J. Cancer"},{"key":"447_CR311","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0959-8049(01)00004-1","volume":"37","author":"CA Stiller","year":"2001","unstructured":"Stiller, C. A., Craft, A. W. & Corazziari, I. Survival of children with bone sarcoma in Europe since 1978. Eur. J. Cancer 37, 760\u2013766 (2001).","journal-title":"Eur. J. Cancer"},{"key":"447_CR312","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1634\/theoncologist.7-2-144","volume":"7","author":"S Arthur P","year":"2002","unstructured":"Arthur P, S., Richard, L., Keith, R., Joseph B, S. & Michael, W. Osteogenic sarcoma presenting with lung metastasis. Oncologist 7, 144\u2013153 (2002).","journal-title":"Oncologist"},{"key":"447_CR313","first-page":"55","volume":"9","author":"JD Lamplot","year":"2013","unstructured":"Lamplot, J. D. et al. The current and future therapies for human osteosarcoma. Curr. Cancer Ther. Rev. 9, 55\u201377 (2013).","journal-title":"Curr. Cancer Ther. Rev."},{"key":"447_CR314","doi-asserted-by":"crossref","unstructured":"Finkel, M. P., Reilly, C. A. Jr, Biskis, B. O. Pathogenesis of radiation and virus-induced bone tumors. Recent Results Cancer Res. 54, 92\u2013103 (1976).","DOI":"10.1007\/978-3-642-80997-2_7"},{"key":"447_CR315","doi-asserted-by":"crossref","unstructured":"Swaney J. J. Familial osteogenic sarcoma. Clin. Orthop. Relat. Res. 97, 64\u201368 (1973).","DOI":"10.1097\/00003086-197311000-00010"},{"key":"447_CR316","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1200\/JCO.1994.12.5.925","volume":"12","author":"JF McIntyre","year":"1994","unstructured":"McIntyre, J. F. et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J. Clin. Oncol. 12, 925\u2013930 (1994).","journal-title":"J. Clin. Oncol."},{"key":"447_CR317","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10637-021-01161-y","volume":"40","author":"K Tsogtbaatar","year":"2021","unstructured":"Tsogtbaatar, K. et al. In vitro selection of DNA aptamers against human osteosarcoma. Investig. N. Drugs 40, 172\u2013181 (2021).","journal-title":"Investig. N. Drugs"},{"key":"447_CR318","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.talanta.2018.05.011","volume":"188","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging. Talanta 188, 66\u201373 (2018).","journal-title":"Talanta"},{"key":"447_CR319","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biomaterials.2017.09.015","volume":"147","author":"C Liang","year":"2017","unstructured":"Liang, C. et al. Tumor cell-targeted delivery of CRISPR\/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma. Biomaterials 147, 68\u201385 (2017).","journal-title":"Biomaterials"},{"key":"447_CR320","doi-asserted-by":"crossref","unstructured":"Yu Z. et al. Epidermal growth factor receptor aptamer\u2011conjugated polymer\u2011lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells. Exp Ther Med 15, 1247\u20131256 (2017).","DOI":"10.3892\/etm.2017.5578"},{"key":"447_CR321","doi-asserted-by":"publisher","first-page":"963689722114494","DOI":"10.1177\/09636897221144949","volume":"32","author":"XZ Liu","year":"2023","unstructured":"Liu, X. Z. et al. Aptamer technology and its applications in bone diseases. Cell Transplant. 32, 9636897221144949 (2023).","journal-title":"Cell Transplant."},{"key":"447_CR322","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0145-2126(98)00062-9","volume":"22","author":"S Payda\u015f","year":"1998","unstructured":"Payda\u015f, S., \u015eahin, B., Zorludemir, S. & Hazar, B. All trans retinoic acid as the possible cause of necrotizing vasculitis. Leuk. Res. 22, 655\u2013657 (1998).","journal-title":"Leuk. Res."},{"key":"447_CR323","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/pros.1131","volume":"49","author":"JT Dong","year":"2001","unstructured":"Dong, J. T., Boyd, J. C. & Frierson, H. F. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 49, 166\u2013171 (2001).","journal-title":"Prostate"},{"key":"447_CR324","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3109\/10717544.2014.920059","volume":"23","author":"Z Hao","year":"2014","unstructured":"Hao, Z. et al. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo. Drug Deliv. 23, 864\u2013871 (2014).","journal-title":"Drug Deliv."},{"key":"447_CR325","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr, C. J. Cancer cell cycles. Science 274, 1672\u20131677 (1996).","journal-title":"Science"},{"key":"447_CR326","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35090585","volume":"412","author":"SM Dhanasekaran","year":"2001","unstructured":"Dhanasekaran, S. M. et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822\u2013826 (2001).","journal-title":"Nature"},{"key":"447_CR327","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers, H. Wnt\/\u03b2-catenin signaling in development and disease. Cell 127, 469\u2013480 (2006).","journal-title":"Cell"},{"key":"447_CR328","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci, D. et al. The miR-15a\u2013miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 14, 1271\u20131277 (2008).","journal-title":"Nat. Med."},{"key":"447_CR329","first-page":"965618","volume":"2012","author":"O Eok-Soo","year":"2012","unstructured":"Eok-Soo, O., Motoharu, S., Martin, G. & Jun, C. Cell adhesion in cancer. Int. J. Cell Biol. 2012, 965618 (2012).","journal-title":"Int. J. Cell Biol."},{"key":"447_CR330","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jso.2930530508","volume":"53","author":"G Bazzoni","year":"1993","unstructured":"Bazzoni, G., Mart\u00edn-Padura, I., Beltr\u00e0n-Nu\u00f1ez, A. & Dejana, E. Tumor cell adhesion receptors. J. Surg. Oncol. 53, 24\u201327 (1993).","journal-title":"J. Surg. Oncol."},{"key":"447_CR331","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jcb.10662","volume":"91","author":"K Evan T","year":"2004","unstructured":"Evan T, K. & Julie, B. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J. Cell Biochem. 91, 718\u2013729 (2004).","journal-title":"J. Cell Biochem."},{"key":"447_CR332","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard, C. & Larriv\u00e9e, B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis 20, 409\u2013426 (2017).","journal-title":"Angiogenesis"},{"key":"447_CR333","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2741\/3721","volume":"16","author":"C Jun","year":"2011","unstructured":"Jun, C. et al. In pursuit of new anti-angiogenic therapies for cancer treatment. Front. Biosci. 16, 803\u2013814 (2011).","journal-title":"Front. Biosci."},{"key":"447_CR334","first-page":"71","volume":"12","author":"D Rana","year":"2022","unstructured":"Rana, D. et al. Spatiotemporally controlled, aptamers-mediated growth factor release locally manipulates microvasculature formation within engineered tissues. Bioact. Mater. 12, 71\u201384 (2022).","journal-title":"Bioact. Mater."},{"key":"447_CR335","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.201703-0660OC","volume":"197","author":"D Ajona","year":"2018","unstructured":"Ajona, D. et al. Blockade of the complement C5a\/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects. Am. J. Respir. Crit. Care Med. 197, 1164\u20131176 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"447_CR336","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.surg.2017.07.027","volume":"163","author":"MC Kuo","year":"2018","unstructured":"Kuo, M. C., Kothari, A. N., Kuo, P. C. & Mi, Z. Cancer stemness in bone marrow micrometastases of human breast cancer. Surgery 163, 330\u2013335 (2018).","journal-title":"Surgery"},{"key":"447_CR337","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s00774-023-01403-4","volume":"41","author":"J Teramachi","year":"2023","unstructured":"Teramachi, J. et al. Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents. J. Bone Miner. Metab. 41, 388\u2013403 (2023).","journal-title":"J. Bone Miner. Metab."},{"key":"447_CR338","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","volume":"7","author":"R Bataille","year":"1989","unstructured":"Bataille, R. et al. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J. Clin. Oncol. 7, 1909\u20131914 (1989).","journal-title":"J. Clin. Oncol."},{"key":"447_CR339","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/leu.2008.336","volume":"23","author":"GD Roodman","year":"2008","unstructured":"Roodman, G. D. Pathogenesis of myeloma bone disease. Leukemia 23, 435\u2013441 (2008).","journal-title":"Leukemia"},{"key":"447_CR340","first-page":"2308","volume":"103","author":"L Jun Won","year":"2003","unstructured":"Jun Won, L. et al. IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood 103, 2308\u20132315 (2003).","journal-title":"Blood"},{"key":"447_CR341","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","volume":"321","author":"MS Nanes","year":"2003","unstructured":"Nanes, M. S. Tumor necrosis factor-\u03b1: molecular and cellular mechanisms in skeletal pathology. Gene 321, 1\u201315 (2003).","journal-title":"Gene"},{"key":"447_CR342","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.4049\/jimmunol.173.8.4838","volume":"173","author":"H Kitaura","year":"2004","unstructured":"Kitaura, H. et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-\u03b1-induced osteoclastogenesis in vivo. J. Immunol. 173, 4838\u20134846 (2004).","journal-title":"J. Immunol."},{"key":"447_CR343","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1182\/blood.V100.6.2195","volume":"100","author":"A Masahiro","year":"2002","unstructured":"Masahiro, A. et al. Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood 100, 2195\u20132202 (2002).","journal-title":"Blood"},{"key":"447_CR344","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1038\/leu.2009.136","volume":"23","author":"S Colucci","year":"2009","unstructured":"Colucci, S. et al. Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients. Leukemia 23, 2139\u20132146 (2009).","journal-title":"Leukemia"},{"key":"447_CR345","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.0105-2896.2005.00323.x","volume":"208","author":"LA Ehrlich","year":"2005","unstructured":"Ehrlich, L. A. & Roodman, G. D. The role of immune cells and inflammatory cytokines in Paget\u2019s disease and multiple myeloma. Immunol. Rev. 208, 252\u2013266 (2005).","journal-title":"Immunol. Rev."},{"key":"447_CR346","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2141.2003.04040.x","volume":"120","author":"S Uneda","year":"2002","unstructured":"Uneda, S. et al. Macrophage inflammatory protein\u20101 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br. J. Haematol. 120, 53\u201355 (2002).","journal-title":"Br. J. Haematol."},{"key":"447_CR347","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1182\/blood.V97.11.3349","volume":"97","author":"J-H Han","year":"2001","unstructured":"Han, J.-H. et al. Macrophage inflammatory protein-1\u03b1 is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor \u03baB ligand. Blood 97, 3349\u20133353 (2001).","journal-title":"Blood"},{"key":"447_CR348","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","volume":"101","author":"S Lentzsch","year":"2003","unstructured":"Lentzsch, S. et al. Macrophage inflammatory protein 1-alpha (MIP-1\u03b1) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 101, 3568\u20133573 (2003).","journal-title":"Blood"},{"key":"447_CR349","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/leu.2011.43","volume":"25","author":"S Vallet","year":"2011","unstructured":"Vallet, S. et al. A novel role for CCL3 (MIP-1\u03b1) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function. Leukemia 25, 1174\u20131181 (2011).","journal-title":"Leukemia"},{"key":"447_CR350","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1182\/blood-2016-03-707547","volume":"128","author":"G An","year":"2016","unstructured":"An, G. et al. Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication. Blood 128, 1590\u20131603 (2016).","journal-title":"Blood"},{"key":"447_CR351","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450\u2013461 (2015).","journal-title":"Cancer Cell"},{"key":"447_CR352","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi, M. Skeletal remodeling in health and disease. Nat. Med. 13, 791\u2013801 (2007).","journal-title":"Nat. Med."},{"key":"447_CR353","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11914-017-0397-5","volume":"15","author":"C Panaroni","year":"2017","unstructured":"Panaroni, C., Yee, A. J. & Raje, N. S. Myeloma and bone disease. Curr. Osteoporos. Rep. 15, 483\u2013498 (2017).","journal-title":"Curr. Osteoporos. Rep."},{"key":"447_CR354","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179\u2013192 (2013).","journal-title":"Nat. Med."},{"key":"447_CR355","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"T Erming","year":"2003","unstructured":"Erming, T. et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N. Engl. J. Med 349, 2483\u20132494 (2003).","journal-title":"N. Engl. J. Med"},{"key":"447_CR356","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1182\/blood-2004-12-4940","volume":"106","author":"T Oshima","year":"2005","unstructured":"Oshima, T. et al. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 106, 3160\u20133165 (2005).","journal-title":"Blood"},{"key":"447_CR357","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1158\/0008-5472.CAN-06-4666","volume":"67","author":"N Giuliani","year":"2007","unstructured":"Giuliani, N. et al. Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment. Cancer Res. 67, 7665\u20137674 (2007).","journal-title":"Cancer Res."},{"key":"447_CR358","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1038\/bcj.2011.22","volume":"1","author":"S Colucci","year":"2011","unstructured":"Colucci, S. et al. Myeloma cells suppress osteoblasts through sclerostin secretion. Blood Cancer J. 1, e27\u2013e27 (2011).","journal-title":"Blood Cancer J."},{"key":"447_CR359","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1182\/blood-2007-03-077685","volume":"111","author":"CM Edwards","year":"2008","unstructured":"Edwards, C. M. et al. Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo. Blood 111, 2833\u20132842 (2008).","journal-title":"Blood"},{"key":"447_CR360","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1182\/blood-2006-09-047712","volume":"109","author":"S Yaccoby","year":"2006","unstructured":"Yaccoby, S. et al. Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood 109, 2106\u20132111 (2006).","journal-title":"Blood"},{"key":"447_CR361","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1182\/blood-2008-11-191577","volume":"114","author":"M Fulciniti","year":"2009","unstructured":"Fulciniti, M. et al. Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma. Blood 114, 371\u2013379 (2009).","journal-title":"Blood"},{"key":"447_CR362","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bone.2013.01.012","volume":"53","author":"S Pozzi","year":"2013","unstructured":"Pozzi, S. et al. In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma. Bone 53, 487\u2013496 (2013).","journal-title":"Bone"},{"key":"447_CR363","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1182\/blood-2017-03-773341","volume":"129","author":"MM McDonald","year":"2017","unstructured":"McDonald, M. M. et al. Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma. Blood 129, 3452\u20133464 (2017).","journal-title":"Blood"},{"key":"447_CR364","doi-asserted-by":"publisher","first-page":"14515","DOI":"10.1074\/jbc.M700030200","volume":"282","author":"S Kang","year":"2007","unstructured":"Kang, S. et al. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT\/enhancer-binding protein \u03b1 and peroxisome proliferator-activated receptor \u03b3. J. Biol. Chem. 282, 14515\u201314524 (2007).","journal-title":"J. Biol. Chem."},{"key":"447_CR365","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/jcp.25976","volume":"233","author":"H Fairfield","year":"2017","unstructured":"Fairfield, H. et al. The skeletal cell\u2010derived molecule sclerostin drives bone marrow adipogenesis. J. Cell. Physiol. 233, 1156\u20131167 (2017).","journal-title":"J. Cell. Physiol."},{"key":"447_CR366","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13775","volume":"7","author":"EL Scheller","year":"2016","unstructured":"Scheller, E. L. et al. Corrigendum: rRegion-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues. Nat. Commun. 7, 13775 (2016).","journal-title":"Nat. Commun."},{"key":"447_CR367","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","volume":"116","author":"O Landgren","year":"2010","unstructured":"Landgren, O. et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood 116, 1056\u20131059 (2010).","journal-title":"Blood"},{"key":"447_CR368","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.mehy.2005.05.014","volume":"65","author":"R Islam","year":"2005","unstructured":"Islam, R., Altundag, K., Kurt, M., Altundag, O. & Turen, S. Association between obesity and multiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissue. Med. Hypotheses 65, 1001\u20131002 (2005).","journal-title":"Med. Hypotheses"},{"key":"447_CR369","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","volume":"47","author":"A Wallin","year":"2011","unstructured":"Wallin, A. & Larsson, S. C. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur. J. Cancer 47, 1606\u20131615 (2011).","journal-title":"Eur. J. Cancer"},{"key":"447_CR370","doi-asserted-by":"publisher","first-page":"e0119857","DOI":"10.1371\/journal.pone.0119857","volume":"10","author":"Z Kamila Anna","year":"2015","unstructured":"Kamila Anna, Z. et al. Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells. PLoS ONE 10, e0119857 (2015).","journal-title":"PLoS ONE"},{"key":"447_CR371","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.bone.2013.01.009","volume":"53","author":"D Wang","year":"2013","unstructured":"Wang, D., Haile, A. & Jones, L. C. Dexamethasone-induced lipolysis increases the adverse effect of adipocytes on osteoblasts using cells derived from human mesenchymal stem cells. Bone 53, 520\u2013530 (2013).","journal-title":"Bone"},{"key":"447_CR372","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.leukres.2014.12.010","volume":"39","author":"A Jurczyszyn","year":"2015","unstructured":"Jurczyszyn, A. et al. Plasma fatty acid profile in multiple myeloma patients. Leuk. Res. 39, 400\u2013405 (2015).","journal-title":"Leuk. Res."},{"key":"447_CR373","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1210\/en.2013-1712","volume":"155","author":"G Duque","year":"2014","unstructured":"Duque, G., Gimble, J. M., Vidal, C. & Gunaratnam, K. Mechanisms of palmitate-induced lipotoxicity in human osteoblasts. Endocrinology 155, 108\u2013116 (2014).","journal-title":"Endocrinology"},{"key":"447_CR374","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","volume":"20","author":"TH Ambrosi","year":"2017","unstructured":"Ambrosi, T. H. et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell 20, 771\u2013784.e776 (2017).","journal-title":"Cell Stem Cell"},{"key":"447_CR375","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4155\/tde-2021-0041","volume":"12","author":"N Pujol-Navarro","year":"2021","unstructured":"Pujol-Navarro, N. et al. Multiple myeloma: therapeutic delivery of antibodies and aptamers. Ther. Deliv. 12, 705\u2013722 (2021).","journal-title":"Ther. Deliv."},{"key":"447_CR376","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/ph11040108","volume":"11","author":"MM Soldevilla","year":"2018","unstructured":"Soldevilla, M. M., Meraviglia-Crivelli de Caso, D., Menon, A. P. & Pastor, F. Aptamer-iRNAs as therapeutics for cancer treatment. Pharmaceuticals 11, 108 (2018).","journal-title":"Pharmaceuticals"},{"key":"447_CR377","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/leu.2017.5","volume":"31","author":"H Ludwig","year":"2017","unstructured":"Ludwig, H. et al. Olaptesed pegol, an anti-CXCL12\/SDF-1 spiegelmer, alone and with bortezomib\u2013dexamethasone in relapsed\/refractory multiple myeloma: a Phase IIa Study. Leukemia 31, 997\u20131000 (2017).","journal-title":"Leukemia"},{"key":"447_CR378","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1158\/1535-7163.MCT-06-0172","volume":"5","author":"CR Ireson","year":"2006","unstructured":"Ireson, C. R. & Kelland, L. R. Discovery and development of anticancer aptamers. Mol. Cancer Ther. 5, 2957\u20132962 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"447_CR379","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/clpt.2013.58","volume":"94","author":"A Vater","year":"2013","unstructured":"Vater, A. et al. Hematopoietic stem and progenitor cell mobilization in mice and humans by a first-in-class mirror-image oligonucleotide inhibitor of CXCL12. Clin. Pharmacol. Ther. 94, 150\u2013157 (2013).","journal-title":"Clin. Pharmacol. Ther."},{"key":"447_CR380","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1002\/bit.24558","volume":"109","author":"A Aravind","year":"2012","unstructured":"Aravind, A. et al. AS1411 aptamer tagged PLGA\u2010lecithin\u2010PEG nanoparticles for tumor cell targeting and drug delivery. Biotechnol. Bioeng. 109, 2920\u20132931 (2012).","journal-title":"Biotechnol. Bioeng."},{"key":"447_CR381","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher, B. A. & Fricker, S. P. CXCL12 (SDF-1)\/CXCR4 Pathway in cancer. Clin. Cancer Res. 16, 2927\u20132931 (2010).","journal-title":"Clin. Cancer Res."},{"key":"447_CR382","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","volume":"14","author":"F Balkwill","year":"2004","unstructured":"Balkwill, F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14, 171\u2013179 (2004).","journal-title":"Semin. Cancer Biol."},{"key":"447_CR383","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","volume":"49","author":"UM Domanska","year":"2013","unstructured":"Domanska, U. M. et al. A review on CXCR4\/CXCL12 axis in oncology: no place to hide. Eur. J. Cancer 49, 219\u2013230 (2013).","journal-title":"Eur. J. Cancer"},{"key":"447_CR384","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1158\/0008-5472.CAN-15-1926","volume":"76","author":"A Sacco","year":"2016","unstructured":"Sacco, A. et al. Cancer cell dissemination and homing to the bone marrow in a zebrafish model. Cancer Res. 76, 463\u2013471 (2016).","journal-title":"Cancer Res."},{"key":"447_CR385","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.celrep.2014.08.042","volume":"9","author":"AM Roccaro","year":"2014","unstructured":"Roccaro, A. M. et al. SDF-1 inhibition targets the bone marrow niche for cancer therapy. Cell Rep. 9, 118\u2013128 (2014).","journal-title":"Cell Rep."},{"key":"447_CR386","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","volume":"120","author":"A Seckinger","year":"2012","unstructured":"Seckinger, A. et al. Clinical and prognostic role of annexin A2 in multiple myeloma. Blood 120, 1087\u20131094 (2012).","journal-title":"Blood"},{"key":"447_CR387","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.3390\/cancers14215471","volume":"14","author":"A Amundarain","year":"2022","unstructured":"Amundarain, A., Pastor, F., Pr\u00f3sper, F. & Agirre, X. Aptamers, a new therapeutic opportunity for the treatment of multiple myeloma. Cancers 14, 5471 (2022).","journal-title":"Cancers"},{"key":"447_CR388","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1182\/blood-2011-11-393348","volume":"119","author":"S D\u2019Souza","year":"2012","unstructured":"D\u2019Souza, S. et al. Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment. Blood 119, 1888\u20131896 (2012).","journal-title":"Blood"},{"key":"447_CR389","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biochi.2018.06.003","volume":"151","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells. Biochimie 151, 150\u2013158 (2018).","journal-title":"Biochimie"},{"key":"447_CR390","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","volume":"34","author":"N Shah","year":"2020","unstructured":"Shah, N., Chari, A., Scott, E., Mezzi, K. & Usmani, S. Z. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia 34, 985\u20131005 (2020).","journal-title":"Leukemia"},{"key":"447_CR391","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1084\/jem.192.11.1677","volume":"192","author":"P Rennert","year":"2000","unstructured":"Rennert, P. et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member april, inhibits tumor cell growth. J. Exp. Med. 192, 1677\u20131684 (2000).","journal-title":"J. Exp. Med."},{"key":"447_CR392","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20031330","volume":"199","author":"BP O'Connor","year":"2004","unstructured":"O'Connor, B. P. et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199, 91\u201398 (2004).","journal-title":"J. Exp. Med."},{"key":"447_CR393","first-page":"981","volume":"18","author":"S Catuogno","year":"2019","unstructured":"Catuogno, S. et al. An anti-BCMA RNA aptamer for miRNA intracellular delivery. Mol. Ther. 18, 981\u2013990 (2019).","journal-title":"Mol. Ther."},{"key":"447_CR394","first-page":"208","volume":"1806","author":"K Mahtouk","year":"2010","unstructured":"Mahtouk, K., Tjin, E. P. M., Spaargaren, M. & Pals, S. T. The HGF\/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas. Biochim. Biophys. Acta 1806, 208\u2013219 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"447_CR395","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1111\/jcmm.13870","volume":"22","author":"YB Zhang","year":"2018","unstructured":"Zhang, Y. B. et al. Targeting c-met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma. J. Cell. Mol. Med. 22, 5978\u20135990 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"447_CR396","doi-asserted-by":"publisher","first-page":"13131","DOI":"10.1039\/C4CC06016D","volume":"50","author":"R Ueki","year":"2014","unstructured":"Ueki, R. & Sando, S. A DNA aptamer to c-Met inhibits cancer cell migration. Chem. Commun. 50, 13131\u201313134 (2014).","journal-title":"Chem. Commun."},{"key":"447_CR397","doi-asserted-by":"publisher","first-page":"21896","DOI":"10.1074\/jbc.M111.238261","volume":"286","author":"A Boltz","year":"2011","unstructured":"Boltz, A. et al. Bi-specific aptamers mediating tumor cell lysis. J. Biol. Chem. 286, 21896\u201321905 (2011).","journal-title":"J. Biol. Chem."},{"key":"447_CR398","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","volume":"131","author":"NWCJ van de Donk","year":"2018","unstructured":"van de Donk, N. W. C. J., Richardson, P. G. & Malavasi, F. CD38 antibodies in multiple myeloma: back to the future. Blood 131, 13\u201329 (2018).","journal-title":"Blood"},{"key":"447_CR399","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/leu.2015.216","volume":"30","author":"J Wen","year":"2015","unstructured":"Wen, J., Tao, W., Hao, S., Iyer, S. P. & Zu, Y. A unique aptamer-drug conjugate for targeted therapy of multiple myeloma. Leukemia 30, 987\u2013991 (2015).","journal-title":"Leukemia"},{"key":"447_CR400","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","volume":"21","author":"T Neogi","year":"2013","unstructured":"Neogi, T. The epidemiology and impact of pain in osteoarthritis. Osteoarthr. Cartil. 21, 1145\u20131153 (2013).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR401","first-page":"92","volume":"12","author":"R Ewa M","year":"2015","unstructured":"Ewa M, R. & Nigel K, A. Strategies for the prevention of knee osteoarthritis. Nat. Rev. Rheumatol. 12, 92\u2013101 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"447_CR402","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","volume":"2","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier, J. et al. Osteoarthritis. Nat. Rev. Dis. Prim. 2, 16072 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"447_CR403","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones, S. et al. Osteoarthritis. Lancet 386, 376\u2013387 (2015).","journal-title":"Lancet"},{"key":"447_CR404","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rdc.2012.10.004","volume":"39","author":"T Neogi","year":"2013","unstructured":"Neogi, T. & Zhang, Y. Epidemiology of osteoarthritis. Rheum. Dis. Clin. North Am. 39, 1\u201319 (2013).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"447_CR405","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2007","unstructured":"Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum. 58, 26\u201335 (2007).","journal-title":"Arthritis Rheum."},{"key":"447_CR406","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.joca.2015.05.009","volume":"23","author":"BA Christiansen","year":"2015","unstructured":"Christiansen, B. A. et al. Non-invasive mouse models of post-traumatic osteoarthritis. Osteoarthr. Cartil. 23, 1627\u20131638 (2015).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR407","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13018-016-0346-5","volume":"11","author":"EL Kuyinu","year":"2016","unstructured":"Kuyinu, E. L., Narayanan, G., Nair, L. S. & Laurencin, C. T. Animal models of osteoarthritis: classification, update, and measurement of outcomes. J. Orthop. Surg. Res. 11, 19 (2016).","journal-title":"J. Orthop. Surg. Res."},{"key":"447_CR408","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","volume":"23","author":"VB Kraus","year":"2015","unstructured":"Kraus, V. B., Blanco, F. J., Englund, M., Karsdal, M. A. & Lohmander, L. S. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthr. Cartil. 23, 1233\u20131241 (2015).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR409","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMcp1903768","volume":"384","author":"L Sharma","year":"2021","unstructured":"Sharma, L. & Solomon, C. G. Osteoarthritis of the Knee. N. Engl. J. Med. 384, 51\u201359 (2021).","journal-title":"N. Engl. J. Med."},{"key":"447_CR410","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/annrheumdis-2020-218469","volume":"80","author":"M-L Ji","year":"2021","unstructured":"Ji, M.-L. et al. Precise targeting of miR-141\/200c cluster in chondrocytes attenuates osteoarthritis development. Ann. Rheum. Dis. 80, 356\u2013366 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"447_CR411","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1874312901105010100","volume":"5","author":"MD Smith","year":"2011","unstructured":"Smith, M. D. The normal synovium. Open Rheumatol. J. 5, 100\u2013106 (2011).","journal-title":"Open Rheumatol. J."},{"key":"447_CR412","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/scrt501","volume":"5","author":"EB de Sousa","year":"2015","unstructured":"de Sousa, E. B., Casado, P. L., Moura Neto, V., Duarte, M. E. & Aguiar, D. P. Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives. Stem Cell Res. Ther. 5, 112 (2015).","journal-title":"Stem Cell Res. Ther."},{"key":"447_CR413","first-page":"594","volume":"27","author":"GD Jay","year":"2000","unstructured":"Jay, G. D., Britt, D. E. & Cha, C. J. Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts. J. Rheumatol. 27, 594\u2013600 (2000).","journal-title":"J. Rheumatol."},{"key":"447_CR414","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.matbio.2014.08.008","volume":"39","author":"GD Jay","year":"2014","unstructured":"Jay, G. D. & Waller, K. A. The biology of lubricin: near frictionless joint motion. Matrix Biol. 39, 17\u201324 (2014).","journal-title":"Matrix Biol."},{"key":"447_CR415","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","volume":"51","author":"CR Scanzello","year":"2012","unstructured":"Scanzello, C. R. & Goldring, S. R. The role of synovitis in osteoarthritis pathogenesis. Bone 51, 249\u2013257 (2012).","journal-title":"Bone"},{"key":"447_CR416","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","volume":"18","author":"E Sanchez-Lopez","year":"2022","unstructured":"Sanchez-Lopez, E., Coras, R., Torres, A., Lane, N. E. & Guma, M. Synovial inflammation in osteoarthritis progression. Nat. Rev. Rheumatol. 18, 258\u2013275 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"447_CR417","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13075-015-0605-6","volume":"17","author":"S Ni","year":"2015","unstructured":"Ni, S. et al. The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-\u03baB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation. Arthritis Res. Ther. 17, 91 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"447_CR418","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2010","unstructured":"Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P. & Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33\u201342 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"447_CR419","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semcdb.2019.12.006","volume":"101","author":"T Pap","year":"2020","unstructured":"Pap, T., Dankbar, B., Wehmeyer, C., Korb-Pap, A. & Sherwood, J. Synovial fibroblasts and articular tissue remodelling: role and mechanisms. Semin. Cell Dev. Biol. 101, 140\u2013145 (2020).","journal-title":"Semin. Cell Dev. Biol."},{"key":"447_CR420","first-page":"202109460","volume":"32","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Specific clearance of senescent synoviocytes suppresses the development of osteoarthritis based on aptamer-functionalized targeted drug delivery system. Adv. Funct. Mater. 32, 202109460 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"447_CR421","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775\u2013781 (2017).","journal-title":"Nat. Med."},{"key":"447_CR422","doi-asserted-by":"publisher","first-page":"107905","DOI":"10.1016\/j.intimp.2021.107905","volume":"99","author":"R Zhao","year":"2021","unstructured":"Zhao, R. et al. Inflammatory factors are crucial for the pathogenesis of post-traumatic osteoarthritis confirmed by a novel porcine model: \u201cIdealized\u201d anterior cruciate ligament reconstruction\u201d and gait analysis. Int. Immunopharmacol. 99, 107905 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"447_CR423","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/561459","volume":"2014","author":"P Wojdasiewicz","year":"2014","unstructured":"Wojdasiewicz, P., Poniatowski, \u0141. A. & Szukiewicz, D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat. Inflamm. 2014, 1\u201319 (2014).","journal-title":"Mediat. Inflamm."},{"key":"447_CR424","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/138945010791011938","volume":"11","author":"KB Marcu","year":"2010","unstructured":"Marcu, K. B., Otero, M., Olivotto, E., Borzi, R. M. & Goldring, M. B. NF-kappaB signaling: multiple angles to target OA. Curr. Drug Targets 11, 599\u2013613 (2010).","journal-title":"Curr. Drug Targets"},{"key":"447_CR425","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.aanat.2005.06.007","volume":"187","author":"M Shakibaei","year":"2005","unstructured":"Shakibaei, M., Schulze-Tanzil, G., John, T. & Mobasheri, A. Curcumin protects human chondrocytes from IL-1\u03b2-induced inhibition of collagen type II and \u03b21-integrin expression and activation of caspase-3: an immunomorphological study. Ann. Anat. 187, 487\u2013497 (2005).","journal-title":"Ann. Anat."},{"key":"447_CR426","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000055915","volume":"68","author":"J St\u00f6ve","year":"2000","unstructured":"St\u00f6ve, J., Huch, K., G\u00fcnther, K.-P. & Scharf, H.-P. Interleukin-1\u03b2 induces different gene expression of stromelysin, aggrecan and tumor-necrosis-factor-stimulated gene 6 in human osteoarthritic chondrocytes in vitro. Pathobiology 68, 144\u2013149 (2000).","journal-title":"Pathobiology"},{"key":"447_CR427","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4","volume":"43","author":"JA Mengshol","year":"2000","unstructured":"Mengshol, J. A., Vincenti, M. P., Coon, C. I., Barchowsky, A. & Brinckerhoff, C. E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor \u03baB: Differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43, 801\u2013811 (2000).","journal-title":"Arthritis Rheum."},{"key":"447_CR428","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/ar401","volume":"4","author":"MP Vincenti","year":"2002","unstructured":"Vincenti, M. P. & Brinckerhoff, C. E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. Ther. 4, 157\u2013164 (2002).","journal-title":"Arthritis Res. Ther."},{"key":"447_CR429","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/2040622312454157","volume":"3","author":"E Meszaros","year":"2013","unstructured":"Meszaros, E. & Malemud, C. J. Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. Ther. Adv. Chronic Dis. 3, 219\u2013229 (2013).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"447_CR430","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1002\/jcb.23298","volume":"112","author":"P Verma","year":"2011","unstructured":"Verma, P. & Dalal, K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J. Cell. Biochem. 112, 3507\u20133514 (2011).","journal-title":"J. Cell. Biochem."},{"key":"447_CR431","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.smim.2013.10.001","volume":"25","author":"CA Dinarello","year":"2013","unstructured":"Dinarello, C. A. Overview of the interleukin-1 family of ligands and receptors. Semin. Immunol. 25, 389\u2013393 (2013).","journal-title":"Semin. Immunol."},{"key":"447_CR432","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/1529-0131(199908)42:8<1577::AID-ANR3>3.0.CO;2-Z","volume":"42","author":"N Saha","year":"1999","unstructured":"Saha, N. et al. Interleukin-1\u03b2-converting enzyme\/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1\u03b2 and interleukin-18. Arthritis Rheum. 42, 1577\u20131587 (1999).","journal-title":"Arthritis Rheum."},{"key":"447_CR433","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.4049\/jimmunol.162.2.1096","volume":"162","author":"T Olee","year":"1999","unstructured":"Olee, T., Hashimoto, S., Quach, J. & Lotz, M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J. Immunol. 162, 1096\u20131100 (1999).","journal-title":"J. Immunol."},{"key":"447_CR434","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/rheumatology\/keg146","volume":"42","author":"M B","year":"2003","unstructured":"B, M. et al. Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes. Rheumatol. 42, 442\u2013445 (2003).","journal-title":"Rheumatol."},{"key":"447_CR435","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1084\/jem.185.6.1005","volume":"185","author":"N Udagawa","year":"1997","unstructured":"Udagawa, N. et al. Interleukin-18 (Interferon-\u03b3\u2013inducing factor) is produced by osteoblasts and acts via granulocyte\/macrophage colony-stimulating factor and not via interferon-\u03b3 to inhibit osteoclast formation. J. Exp. Med. 185, 1005\u20131012 (1997).","journal-title":"J. Exp. Med."},{"key":"447_CR436","first-page":"862","volume":"31","author":"P Cheng-zhong","year":"2007","unstructured":"Cheng-zhong, P. et al. Concentration of IL-18 and PGE2 in synovial fluid in patients with osteoarthritis and its significance. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31, 862\u2013865 (2007).","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"447_CR437","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10238-013-0251-8","volume":"14","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Correlation between plasma, synovial fluid and articular cartilage Interleukin-18 with radiographic severity in 33 patients with osteoarthritis of the knee. Clin. Exp. Med. 14, 297\u2013304 (2013).","journal-title":"Clin. Exp. Med."},{"key":"447_CR438","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1073\/pnas.1012743108","volume":"108","author":"AE Denoble","year":"2011","unstructured":"Denoble, A. E. et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc. Natl. Acad. Sci. USA 108, 2088\u20132093 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"447_CR439","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/ard.2004.026088","volume":"64","author":"SM Dai","year":"2005","unstructured":"Dai, S. M., Shan, Z. Z., Nishioka, K. & Yudoh, K. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal. Ann. Rheum. Dis. 64, 735\u2013742 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"447_CR440","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0002-9440(10)63357-3","volume":"165","author":"LAB Joosten","year":"2004","unstructured":"Joosten, L. A. B. et al. Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction. Am. J. Pathol. 165, 959\u2013967 (2004).","journal-title":"Am. J. Pathol."},{"key":"447_CR441","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bone.2008.01.031","volume":"42","author":"H Inoue","year":"2008","unstructured":"Inoue, H. et al. High levels of serum IL-18 promote cartilage loss through suppression of aggrecan synthesis. Bone 42, 1102\u20131110 (2008).","journal-title":"Bone"},{"key":"447_CR442","first-page":"469","volume":"22","author":"T John","year":"2007","unstructured":"John, T., Kohl, B., Mobasheri, A., Ertel, W. & Shakibaei, M. Interleukin-18 induces apoptosis in human articular chondrocytes. Histol. Histopathol. 22, 469\u2013482 (2007).","journal-title":"Histol. Histopathol."},{"key":"447_CR443","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1097\/00002371-200203001-00009","volume":"25","author":"H Futani","year":"2002","unstructured":"Futani, H. et al. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J. Immunother. 25, S61\u2013S64 (2002).","journal-title":"J. Immunother."},{"key":"447_CR444","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.imlet.2005.10.020","volume":"103","author":"M Cho","year":"2006","unstructured":"Cho, M. et al. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol. Lett. 103, 159\u2013166 (2006).","journal-title":"Immunol. Lett."},{"key":"447_CR445","first-page":"729","volume":"29","author":"L Yong","year":"2009","unstructured":"Yong, L., Jian-ming, J., De-hong, Y., Feng-long, W. & Zhong-xuan, M. Determination of the concentrations of interleukin-18 and other cytokines in the synovial fluid in patients with osteoarthritis. Nan Fang Yi Ke Da Xue Xue Bao 29, 729\u2013731 (2009).","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"447_CR446","first-page":"731","volume":"30","author":"W Feng-long","year":"2010","unstructured":"Feng-long, W., Jian-ming, J., Fei, W., Zhao-zong, F. & Zhao-fei, Z. [Expressions of interleukin 18 and prostaglandin E2 and their correlation in the synoviocytes of patients with osteoarthritis]. Nan Fang. Yi Ke Da Xue Xue Bao 30, 731\u2013733 (2010).","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"key":"447_CR447","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/322547a0","volume":"322","author":"J Saklatvala","year":"1986","unstructured":"Saklatvala, J. Tumour necrosis factor \u03b1 stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322, 547\u2013549 (1986).","journal-title":"Nature"},{"key":"447_CR448","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/jcp.10371","volume":"197","author":"CA S\u00e9guin","year":"2003","unstructured":"S\u00e9guin, C. A. & Bernier, S. M. TNF\u03b1 suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1\/2 and NF\u2010\u03baB signaling pathways. J. Cell. Physiol. 197, 356\u2013369 (2003).","journal-title":"J. Cell. Physiol."},{"key":"447_CR449","first-page":"306","volume":"75","author":"B Henderson","year":"1989","unstructured":"Henderson, B. & Pettipher, E. R. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin. Exp. Immunol. 75, 306\u2013310 (1989).","journal-title":"Clin. Exp. Immunol."},{"key":"447_CR450","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/art.10212","volume":"46","author":"PJT Koshy","year":"2002","unstructured":"Koshy, P. J. T. et al. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin\u20101 and oncostatin M: a time\u2010course study using real\u2010time quantitative reverse transcription\u2013polymerase chain reaction. Arthritis Rheum.46, 961\u2013967 (2002).","journal-title":"Arthritis Rheum."},{"key":"447_CR451","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1139\/cjpp-2013-0228","volume":"92","author":"Z Ye","year":"2014","unstructured":"Ye, Z. et al. c-Jun N-terminal kinase\u2013c-Jun pathway transactivates Bim to promote osteoarthritis. Can. J. Physiol. Pharmacol. 92, 132\u2013139 (2014).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"447_CR452","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1136\/ard.59.12.959","volume":"59","author":"F H\u00e9raud","year":"2000","unstructured":"H\u00e9raud, F., H\u00e9raud, A. & Harmand, M. F. Apoptosis in normal and osteoarthritic human articular cartilage. Ann. Rheum. Dis. 59, 959\u2013965 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"447_CR453","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.joca.2006.03.008","volume":"14","author":"MJ L\u00f3pez-Armada","year":"2006","unstructured":"L\u00f3pez-Armada, M. J. et al. Mitochondrial activity is modulated by TNF\u03b1 and IL-1\u03b2 in normal human chondrocyte cells. Osteoarthr. Cartil. 14, 1011\u20131022 (2006).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR454","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.joca.2006.01.005","volume":"14","author":"MJ L\u00f3pez-Armada","year":"2006","unstructured":"L\u00f3pez-Armada, M. J. et al. Cytokines, tumor necrosis factor-\u03b1 and interleukin-1\u03b2, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthr. Cartil. 14, 660\u2013669 (2006).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR455","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4049\/jimmunol.144.2.499","volume":"144","author":"PA Guerne","year":"1990","unstructured":"Guerne, P. A., Carson, D. A. & Lotz, M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J. Immunol. 144, 499\u2013505 (1990).","journal-title":"J. Immunol."},{"key":"447_CR456","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4049\/jimmunol.148.2.466","volume":"148","author":"M Lotz","year":"1992","unstructured":"Lotz, M., Terkeltaub, R. & Villiger, P. M. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J. Immunol. 148, 466\u2013473 (1992).","journal-title":"J. Immunol."},{"key":"447_CR457","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z","volume":"44","author":"N Alaaeddine","year":"2001","unstructured":"Alaaeddine, N., Olee, T., Hashimoto, S., Creighton-Achermann, L. & Lotz, M. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum. 44, 1633\u20131643 (2001).","journal-title":"Arthritis Rheum."},{"key":"447_CR458","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/03008200701541767","volume":"48","author":"MC Honorati","year":"2009","unstructured":"Honorati, M. C., Cattini, L. & Facchini, A. VEGF production by osteoarthritic chondrocytes cultured in micromass and stimulated by IL-17 and TNF-\u03b1. Connect. Tissue Res. 48, 239\u2013245 (2009).","journal-title":"Connect. Tissue Res."},{"key":"447_CR459","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"KT Steeve","year":"2004","unstructured":"Steeve, K. T., Marc, P., Sandrine, T., Dominique, H. & Yannick, F. IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15, 49\u201360 (2004).","journal-title":"Cytokine Growth Factor Rev."},{"key":"447_CR460","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00774-009-0058-6","volume":"27","author":"K Sakao","year":"2009","unstructured":"Sakao, K. et al. Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. J. Bone Miner. Metab. 27, 412\u2013423 (2009).","journal-title":"J. Bone Miner. Metab."},{"key":"447_CR461","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.4238\/vol10-3gmr1161","volume":"10","author":"S Honsawek","year":"2011","unstructured":"Honsawek, S. et al. Association of the IL-6 -174G\/C gene polymorphism with knee osteoarthritis in a Thai population. Genet. Mol. Res. 10, 1674\u20131680 (2011).","journal-title":"Genet. Mol. Res."},{"key":"447_CR462","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.joca.2005.07.011","volume":"13","author":"P E","year":"2005","unstructured":"E, P. et al. Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study. Osteoarthr. Cartil. 13, 1025\u20131028 (2005).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR463","first-page":"4850","volume":"283","author":"P Beno\u00eet","year":"2007","unstructured":"Beno\u00eet, P. et al. Interleukin-6 (IL-6) and\/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J. Biol. Chem. 283, 4850\u20134865 (2007).","journal-title":"J. Biol. Chem."},{"key":"447_CR464","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B","volume":"44","author":"AD Rowan","year":"2001","unstructured":"Rowan, A. D. et al. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum. 44, 1620\u20131632 (2001).","journal-title":"Arthritis Rheum."},{"key":"447_CR465","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M","volume":"41","author":"TE Cawston","year":"1998","unstructured":"Cawston, T. E. et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum. 41, 1760\u20131771 (1998).","journal-title":"Arthritis Rheum."},{"key":"447_CR466","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.joca.2004.09.011","volume":"13","author":"ASK de Hooge","year":"2005","unstructured":"de Hooge, A. S. K. et al. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthr. Cartil. 13, 66\u201373 (2005).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR467","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1749-6632.1994.tb44245.x","volume":"730","author":"SL Kunkel","year":"2006","unstructured":"Kunkel, S. L., Lukacs, N. W. & Strieter, R. M. The role of interleukin\u20108 in the infectious process. Ann. N. Y. Acad. Sci. 730, 134\u2013143 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"447_CR468","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1165\/ajrcmb\/5.5.493","volume":"5","author":"MW Rolfe","year":"1991","unstructured":"Rolfe, M. W. et al. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am. J. Respir. Cell Mol. Biol. 5, 493\u2013501 (1991).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"447_CR469","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1172\/JCI114928","volume":"86","author":"TJ Standiford","year":"1990","unstructured":"Standiford, T. J. et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Investig. 86, 1945\u20131953 (1990).","journal-title":"J. Clin. Investig."},{"key":"447_CR470","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485\u2013517 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"447_CR471","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2478\/v10042-009-0117-9","volume":"47","author":"J Paw\u0142owska","year":"2010","unstructured":"Paw\u0142owska, J. et al. Different distribution of CD4 and CD8 T cells in synovial membrane and peripheral blood of rheumatoid arthritis and osteoarthritis patients. Folia Histochem. Cytobiol. 47, 627\u2013632 (2010).","journal-title":"Folia Histochem. Cytobiol."},{"key":"447_CR472","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/joca.2001.0509","volume":"10","author":"H Ishii","year":"2002","unstructured":"Ishii, H. et al. Characterization of infiltrating T cells and Th1\/Th2-type cytokines in the synovium of patients with osteoarthritis. Osteoarthr. Cartil. 10, 277\u2013281 (2002).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR473","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/art.1780331004","volume":"33","author":"S Alsalameh","year":"2005","unstructured":"Alsalameh, S. et al. Cellular immune response toward human articular chondrocytes. T cell reactivities against chondrocyte and fibroblast membranes in destructive joint diseases. Arthritis Rheum. 33, 1477\u20131486 (2005).","journal-title":"Arthritis Rheum."},{"key":"447_CR474","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D","volume":"43","author":"E Lubberts","year":"2000","unstructured":"Lubberts, E., Joosten, L. A., Van De Loo, F. A., Van Den Gersselaar, L. A. & Van Den Berg, W. B. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. Arthritis Rheum. 43, 1300\u20131306 (2000).","journal-title":"Arthritis Rheum."},{"key":"447_CR475","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/1529-0131(199911)42:11<2399::AID-ANR19>3.0.CO;2-Y","volume":"42","author":"J Martel-Pelletier","year":"1999","unstructured":"Martel-Pelletier, J., Mineau, F. O., Jovanovic, D., Di Battista, J. A. & Pelletier, J.-P. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arthritis Rheum. 42, 2399\u20132409 (1999).","journal-title":"Arthritis Rheum."},{"key":"447_CR476","first-page":"1262","volume":"29","author":"B Mohamed","year":"2002","unstructured":"Mohamed, B. et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. J. Rheumatol. 29, 1262\u20131272 (2002).","journal-title":"J. Rheumatol."},{"key":"447_CR477","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/1529-0131(200109)44:9<2078::AID-ART358>3.0.CO;2-J","volume":"44","author":"A LeGrand","year":"2001","unstructured":"LeGrand, A. et al. Interleukin-1, tumor necrosis factor, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum. 44, 2078\u20132083 (2001).","journal-title":"Arthritis Rheum."},{"key":"447_CR478","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/joca.2002.0829","volume":"10","author":"MC Honorati","year":"2002","unstructured":"Honorati, M. C., Bovara, M., Cattini, L., Piacentini, A. & Facchini, A. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthr. Cartil. 10, 799\u2013807 (2002).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR479","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/art.1780400609","volume":"40","author":"MG Attur","year":"2005","unstructured":"Attur, M. G., Patel, R. N., Abramson, S. B. & Amin, A. R. Interleukin\u201017 up\u2010regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum. 40, 1050\u20131053 (2005).","journal-title":"Arthritis Rheum."},{"key":"447_CR480","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.joca.2005.10.004","volume":"14","author":"MC Honorati","year":"2006","unstructured":"Honorati, M. C., Neri, S., Cattini, L. & Facchini, A. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthr. Cartil. 14, 345\u2013352 (2006).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR481","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.gene.2013.09.113","volume":"533","author":"L Han","year":"2014","unstructured":"Han, L. et al. Association of IL-17A and IL-17F single nucleotide polymorphisms with susceptibility to osteoarthritis in a Korean population. Gene 533, 119\u2013122 (2014).","journal-title":"Gene"},{"key":"447_CR482","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.biochi.2011.04.003","volume":"93","author":"H Adachi","year":"2011","unstructured":"Adachi, H. et al. Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A\/F. Biochimie 93, 1081\u20131088 (2011).","journal-title":"Biochimie"},{"key":"447_CR483","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/art.21249","volume":"52","author":"B Baslund","year":"2005","unstructured":"Baslund, B. et al. Targeting interleukin\u201015 in patients with rheumatoid arthritis: a proof\u2010of\u2010concept study. Arthritis Rheum. 52, 2686\u20132692 (2005).","journal-title":"Arthritis Rheum."},{"key":"447_CR484","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm0296-175","volume":"2","author":"IB McInnes","year":"1996","unstructured":"McInnes, I. B. et al. The role of interleukin\u201315 in T\u2013cell migration and activation in rheumatoid arthritis. Nat. Med. 2, 175\u2013182 (1996).","journal-title":"Nat. Med."},{"key":"447_CR485","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","volume":"17","author":"TA Waldmann","year":"1999","unstructured":"Waldmann, T. A. & Tagaya, Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in Nk cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17, 19\u201349 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"447_CR486","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.joca.2009.02.011","volume":"17","author":"CR Scanzello","year":"2009","unstructured":"Scanzello, C. R. et al. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthr. Cartil. 17, 1040\u20131048 (2009).","journal-title":"Osteoarthr. Cartil."},{"key":"447_CR487","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini, J. C. et al. Osteogenesis imperfecta. Nat. Rev. Dis. Prim. 3, 17052 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"447_CR488","first-page":"e33864","volume":"15","author":"C Neri Morales","year":"2023","unstructured":"Neri Morales, C. et al. Osteogenesis imperfecta: a case series and literature review. Cureus 15, e33864 (2023).","journal-title":"Cureus"},{"key":"447_CR489","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/ijms22010429","volume":"22","author":"L Bini","year":"2021","unstructured":"Bini, L. et al. Intracellular and extracellular markers of lethality in osteogenesis imperfecta: a quantitative proteomic approach. Int. J. Mol. Sci. 22, 429 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR490","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini, J. C. et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum. Mutat. 28, 209\u2013221 (2007).","journal-title":"Hum. Mutat."},{"key":"447_CR491","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence, D. O., Senn, A. & Danks, D. M. Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 16, 101\u2013116 (1979).","journal-title":"J. Med. Genet."},{"key":"447_CR492","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jped.2014.05.003","volume":"90","author":"ER Valadares","year":"2014","unstructured":"Valadares, E. R., Carneiro, T. B., Santos, P. M., Oliveira, A. C. & Zabel, B. What is new in genetics and osteogenesis imperfecta classification? J. Pediatr. 90, 536\u2013541 (2014).","journal-title":"J. Pediatr."},{"key":"447_CR493","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-014-0151-y","volume":"12","author":"MJ Dogba","year":"2014","unstructured":"Dogba, M. J., Rauch, F., Douglas, E. & Bedos, C. Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta. Health Qual. Life Outcomes 12, 151 (2014).","journal-title":"Health Qual. Life Outcomes"},{"key":"447_CR494","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/biom11101493","volume":"11","author":"M Botor","year":"2021","unstructured":"Botor, M. et al. Osteogenesis imperfecta: current and prospective therapies. Biomolecules 11, 1493 (2021).","journal-title":"Biomolecules"},{"key":"447_CR495","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bone.2016.09.013","volume":"93","author":"JE Perosky","year":"2016","unstructured":"Perosky, J. E. et al. Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl\/+ osteogenesis imperfecta model. Bone 93, 79\u201385 (2016).","journal-title":"Bone"},{"key":"447_CR496","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1530\/JME-18-0176","volume":"62","author":"G Holdsworth","year":"2019","unstructured":"Holdsworth, G., Roberts, S. J. & Ke, H. Z. Novel actions of sclerostin on bone. J. Mol. Endocrinol. 62, R167\u2013R185 (2019).","journal-title":"J. Mol. Endocrinol."},{"key":"447_CR497","doi-asserted-by":"publisher","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","volume":"6","author":"AR Wijenayaka","year":"2011","unstructured":"Wijenayaka, A. R. et al. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS ONE 6, e25900 (2011).","journal-title":"PLoS ONE"},{"key":"447_CR498","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cytogfr.2005.02.005","volume":"16","author":"RL van Bezooijen","year":"2005","unstructured":"van Bezooijen, R. L., ten Dijke, P., Papapoulos, S. E. & L\u00f6wik, C. W. SOST\/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev. 16, 319\u2013327 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"447_CR499","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","volume":"19","author":"KES Poole","year":"2005","unstructured":"Poole, K. E. S. et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 19, 1842\u20131844 (2005).","journal-title":"FASEB J."},{"key":"447_CR500","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/jbmr.3858","volume":"34","author":"AL Scheiber","year":"2019","unstructured":"Scheiber, A. L. et al. Sclerostin antibody-induced changes in bone mass are site specific in developing crania. J. Bone Miner. Res. 34, 2301\u20132310 (2019).","journal-title":"J. Bone Miner. Res."},{"key":"447_CR501","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman, F. et al. Romosozumab treatment in postmenopausal women with osteoporosis. N. Engl. J. Med. 375, 1532\u20131543 (2016).","journal-title":"N. Engl. J. Med."},{"key":"447_CR502","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer, R. M. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434\u20131441 (2001).","journal-title":"N. Engl. J. Med."},{"key":"447_CR503","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","volume":"87","author":"MJC Moester","year":"2010","unstructured":"Moester, M. J. C., Papapoulos, S. E., L\u00f6wik, C. W. G. M. & van Bezooijen, R. L. Sclerostin: current knowledge and future perspectives. Calcif. Tissue Int. 87, 99\u2013107 (2010).","journal-title":"Calcif. Tissue Int."},{"key":"447_CR504","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"Vahle, J. L. et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol. Pathol. 30, 312\u2013321 (2002).","journal-title":"Toxicol. Pathol."},{"key":"447_CR505","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.diff.2012.04.001","volume":"84","author":"A de Vlaming","year":"2012","unstructured":"de Vlaming, A. et al. Atrioventricular valve development: new perspectives on an old theme. Differentiation 84, 103\u2013116 (2012).","journal-title":"Differentiation"},{"key":"447_CR506","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijcard.2016.09.107","volume":"225","author":"L Folkestad","year":"2016","unstructured":"Folkestad, L. et al. Cardiovascular disease in patients with osteogenesis imperfecta\u2013a nationwide, register-based cohort study. Int. J. Cardiol. 225, 250\u2013257 (2016).","journal-title":"Int. J. Cardiol."},{"key":"447_CR507","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.7150\/thno.63177","volume":"12","author":"LY Wang","year":"2022","unstructured":"Wang, L. Y. et al. Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice. Theranostics 12, 5645\u20135674 (2022).","journal-title":"Theranostics"},{"key":"447_CR508","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.omtn.2024.102146","volume":"35","author":"A Gubu","year":"2024","unstructured":"Gubu, A. et al. Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential. Mol. Ther. Nucleic Acids 35, 102146 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"447_CR509","doi-asserted-by":"publisher","first-page":"e86601","DOI":"10.1371\/journal.pone.0086601","volume":"9","author":"IN Sarkar","year":"2014","unstructured":"Sarkar, I. N. et al. Selecting essential information for biosurveillance\u2014a multi-criteria decision analysis. PLoS ONE 9, e86601 (2014).","journal-title":"PLoS ONE"},{"key":"447_CR510","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.4155\/bio-2016-0214","volume":"8","author":"S Summerfield","year":"2016","unstructured":"Summerfield, S., Barfield, M., Spooner, N. & White, S. From patient to tube: the importance of physiologically relevant quantitative bioanalytical assays. Bioanalysis 8, 2595\u20132604 (2016).","journal-title":"Bioanalysis"},{"key":"447_CR511","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1515\/cclm-2022-1016","volume":"61","author":"C Poveda-Rogers","year":"2023","unstructured":"Poveda-Rogers, C. & Morrissette, J. J. D. Greater expectations: meeting clinical needs through broad and rapid genomic testing. Clin. Chem. Lab. Med. 61, 654\u2013661 (2023).","journal-title":"Clin. Chem. Lab. Med."},{"key":"447_CR512","doi-asserted-by":"publisher","first-page":"10106","DOI":"10.1039\/C9NR01589B","volume":"11","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Aptamer-based fluorescence polarization assay for separation-free exosome quantification. Nanoscale 11, 10106\u201310113 (2019).","journal-title":"Nanoscale"},{"key":"447_CR513","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/acssensors.8b01230","volume":"4","author":"XQ Zhang","year":"2019","unstructured":"Zhang, X. Q. et al. Strain H37Rv electrochemical sensor mediated by aptamer and AuNPs-DNA. ACS Sens. 4, 849\u2013855 (2019).","journal-title":"ACS Sens."},{"key":"447_CR514","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01785-7","volume":"21","author":"S Yang","year":"2023","unstructured":"Yang, S. et al. A label-free fluorescent biosensor based on specific aptamer-templated silver nanoclusters for the detection of tetracycline. J. Nanobiotechnol. 21, 22 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"447_CR515","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1021\/ac201314y","volume":"83","author":"J Zheng","year":"2011","unstructured":"Zheng, J. et al. Design of aptamer-based sensing platform using triple-helix molecular switch. Anal. Chem. 83, 6586\u20136592 (2011).","journal-title":"Anal. Chem."},{"key":"447_CR516","doi-asserted-by":"publisher","first-page":"643797","DOI":"10.3389\/fmicb.2021.643797","volume":"12","author":"M Saad","year":"2021","unstructured":"Saad, M. & Faucher, S. P. Aptamers and aptamer-coupled biosensors to detect water-borne pathogens. Front. Microbiol. 12, 643797 (2021).","journal-title":"Front. Microbiol."},{"key":"447_CR517","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2019.07.054","volume":"1082","author":"DP Sun","year":"2019","unstructured":"Sun, D. P., Lu, J., Zhang, L. Y. & Chen, Z. G. Aptamer-based electrochemical cytosensors for tumor cell detection in cancer diagnosis: a review. Anal. Chim. Acta 1082, 1\u201317 (2019).","journal-title":"Anal. Chim. Acta"},{"key":"447_CR518","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1166\/jbn.2018.2634","volume":"14","author":"WR Shin","year":"2018","unstructured":"Shin, W. R. et al. Aptamer-based pathogen monitoring for Salmonella enterica ser. typhimurium. J. Biomed. Nanotechnol. 14, 1992\u20132002 (2018).","journal-title":"J. Biomed. Nanotechnol."},{"key":"447_CR519","doi-asserted-by":"publisher","first-page":"1002285","DOI":"10.3389\/fbioe.2022.1002285","volume":"10","author":"XY Chen","year":"2022","unstructured":"Chen, X. Y., Ma, Y., Xie, Y. Q. & Pu, J. Aptamer-based applications for cardiovascular disease. Front. Bioeng. Biotechnol. 10, 1002285 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"447_CR520","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.3390\/s22155712","volume":"22","author":"H Li","year":"2022","unstructured":"Li, H. et al. Fluorescence assay for detecting four organophosphorus pesticides using fluorescently labeled aptamer. Sensors 22, 5712 (2022).","journal-title":"Sensors"},{"key":"447_CR521","doi-asserted-by":"publisher","first-page":"10456","DOI":"10.1021\/jf801957h","volume":"56","author":"JA Cruz-Aguado","year":"2008","unstructured":"Cruz-Aguado, J. A. & Penner, G. Determination of ochratoxin a with a DNA aptamer. J. Agric. Food Chem. 56, 10456\u201310461 (2008).","journal-title":"J. Agric. Food Chem."},{"key":"447_CR522","doi-asserted-by":"publisher","first-page":"653869","DOI":"10.3389\/fchem.2021.653869","volume":"9","author":"QQ Qiao","year":"2021","unstructured":"Qiao, Q. Q. et al. Aptamer-based fluorescence quenching approach for detection of aflatoxin M1 in milk. Front. Chem. 9, 653869 (2021).","journal-title":"Front. Chem."},{"key":"447_CR523","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/foods11040544","volume":"11","author":"LJ Wang","year":"2022","unstructured":"Wang, L. J., Zhou, H., Hu, H. X., Wang, Q. & Chen, X. G. Regulation mechanism of ssDNA aptamer in nanozymes and application of nanozyme-based aptasensors in food safety. Foods 11, 544 (2022).","journal-title":"Foods"},{"key":"447_CR524","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00216-019-02253-8","volume":"412","author":"Y Qi","year":"2019","unstructured":"Qi, Y. et al. Practical aptamer-based assay of heavy metal mercury ion in contaminated environmental samples: convenience and sensitivity. Anal. Bioanal. Chem. 412, 439\u2013448 (2019).","journal-title":"Anal. Bioanal. Chem."},{"key":"447_CR525","doi-asserted-by":"publisher","first-page":"122743","DOI":"10.1016\/j.talanta.2021.122743","volume":"235","author":"K Ge","year":"2021","unstructured":"Ge, K., Hu, Y. L., Zheng, Y. J., Jiang, P. C. & Li, G. K. Aptamer\/derivatization-based surface-enhanced Raman scattering membrane assembly for selective analysis of melamine and formaldehyde in migration of melamine kitchenware. Talanta 235, 122743 (2021).","journal-title":"Talanta"},{"key":"447_CR526","doi-asserted-by":"publisher","first-page":"9877","DOI":"10.1007\/s00253-020-10940-1","volume":"104","author":"JC Yi","year":"2020","unstructured":"Yi, J. C. et al. The research of aptamer biosensor technologies for detection of microorganism. Appl. Microbiol. Biotechnol. 104, 9877\u20139890 (2020).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"447_CR527","doi-asserted-by":"publisher","first-page":"20214","DOI":"10.1021\/jacs.2c04835","volume":"145","author":"N Chauhan","year":"2022","unstructured":"Chauhan, N. et al. Net-shaped DNA nanostructures designed for rapid\/sensitive detection and potential inhibition of the SARS-CoV-2 virus. J. Am. Chem. Soc. 145, 20214\u201320228 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"447_CR528","doi-asserted-by":"publisher","first-page":"e01136","DOI":"10.1128\/JCM.01136-20","volume":"58","author":"A Basu","year":"2020","unstructured":"Basu, A. et al. Performance of Abbott ID now COVID-19 rapid nucleic acid amplification test using nasopharyngeal swabs transported in viral transport media and dry nasal swabs in a New York City Academic Institution. J. Clin. Microbiol. 58, e01136\u201301120 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"447_CR529","doi-asserted-by":"publisher","first-page":"102960","DOI":"10.1016\/j.ebiom.2020.102960","volume":"59","author":"J Lu","year":"2020","unstructured":"Lu, J. et al. Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. eBioMedicine 59, 102960 (2020).","journal-title":"eBioMedicine"},{"key":"447_CR530","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41587-019-0090-6","volume":"37","author":"JL Litke","year":"2019","unstructured":"Litke, J. L. & Jaffrey, S. R. Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. Nat. Biotechnol. 37, 667\u2013675 (2019).","journal-title":"Nat. Biotechnol."},{"key":"447_CR531","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333\u2013338 (2013).","journal-title":"Nature"},{"key":"447_CR532","doi-asserted-by":"publisher","first-page":"e30733","DOI":"10.1371\/journal.pone.0030733","volume":"7","author":"J Salzman","year":"2012","unstructured":"Salzman, J., Gawad, C., Wang, P. L., Lacayo, N. & Brown, P. O. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One 7, e30733 (2012).","journal-title":"PLoS One"},{"key":"447_CR533","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1038\/emboj.2011.359","volume":"30","author":"TB Hansen","year":"2011","unstructured":"Hansen, T. B. et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 30, 4414\u20134422 (2011).","journal-title":"EMBO J."},{"key":"447_CR534","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1261\/rna.048272.114","volume":"21","author":"Y Wang","year":"2015","unstructured":"Wang, Y. & Wang, Z. F. Efficient backsplicing produces translatable circular mRNAs. Rna 21, 172\u2013179 (2015).","journal-title":"Rna"},{"key":"447_CR535","doi-asserted-by":"publisher","first-page":"e1538","DOI":"10.1002\/wrna.1538","volume":"10","author":"HM Li","year":"2019","unstructured":"Li, H. M., Ma, X. L. & Li, H. G. Intriguing circles: conflicts and controversies in circular RNA research. WIREs RNA 10, e1538 (2019).","journal-title":"WIREs RNA"},{"key":"447_CR536","first-page":"1035","volume":"14","author":"E Karoline K","year":"2016","unstructured":"Karoline K, E., Thomas B, H. & J\u00f8rgen, K. Insights into circular RNA biology. RNA Biol. 14, 1035\u20131045 (2016).","journal-title":"RNA Biol."},{"key":"447_CR537","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck, W. R. et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19, 141\u2013157 (2013).","journal-title":"RNA"},{"key":"447_CR538","doi-asserted-by":"publisher","first-page":"1091797","DOI":"10.3389\/fimmu.2022.1091797","volume":"13","author":"Y Bai","year":"2023","unstructured":"Bai, Y. et al. Research progress on circular RNA vaccines. Front. Immunol. 13, 1091797 (2023).","journal-title":"Front. Immunol."},{"key":"447_CR539","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/pathogens13080692","volume":"13","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Advances in engineering circular RNA vaccines. Pathogens 13, 692 (2024).","journal-title":"Pathogens"},{"key":"447_CR540","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s12276-024-01251-w","volume":"56","author":"S-W Choi","year":"2024","unstructured":"Choi, S.-W. & Nam, J.-W. Optimal design of synthetic circular RNAs. Exp. Mol. Med. 56, 1281\u20131292 (2024).","journal-title":"Exp. Mol. Med."},{"key":"447_CR541","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1093\/nar\/gkad554","volume":"51","author":"J Cui","year":"2023","unstructured":"Cui, J. et al. A precise and efficient circular RNA synthesis system based on a ribozyme derived from Tetrahymena thermophila. Nucleic Acids Res. 51, e78\u2013e78 (2023).","journal-title":"Nucleic Acids Res."},{"key":"447_CR542","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1093\/nar\/23.15.3064","volume":"23","author":"D Beadudry","year":"1995","unstructured":"Beadudry, D. & Perreault, J.-P. An efficient strategy for the synthesis of circular RNA molecules. Nucleic Acids Res. 23, 3064\u20133066 (1995).","journal-title":"Nucleic Acids Res."},{"key":"447_CR543","first-page":"587","volume":"33","author":"KH Lee","year":"2023","unstructured":"Lee, K. H. et al. Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using Tetrahymena group I intron ribozyme. Mol. Ther. 33, 587\u2013598 (2023).","journal-title":"Mol. Ther."},{"key":"447_CR544","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/15476286.2023.2272118","volume":"20","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Regulatory circular RNAs in viral diseases: applications in diagnosis and therapy. RNA Biol. 20, 847\u2013858 (2023).","journal-title":"RNA Biol."},{"key":"447_CR545","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).","journal-title":"Nat. Commun."},{"key":"447_CR546","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.molcel.2019.02.015","volume":"74","author":"RA Wesselhoeft","year":"2019","unstructured":"Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell 74, 508\u2013520.e504 (2019).","journal-title":"Mol. Cell"},{"key":"447_CR547","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","volume":"41","author":"R Chen","year":"2022","unstructured":"Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262\u2013272 (2022).","journal-title":"Nat. Biotechnol."}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00447-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:10:10Z","timestamp":1757286610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":547,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1038\/s41413-025-00447-8","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}